<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PeerJ</journal-id><journal-id journal-id-type="iso-abbrev">PeerJ</journal-id><journal-id journal-id-type="publisher-id">PeerJ</journal-id><journal-title-group><journal-title>PeerJ</journal-title></journal-title-group><issn pub-type="epub">2167-8359</issn><publisher><publisher-name>PeerJ Inc.</publisher-name><publisher-loc>San Diego, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12101442</article-id><article-id pub-id-type="publisher-id">19485</article-id><article-id pub-id-type="doi">10.7717/peerj.19485</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Molecular Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Gastroenterology and Hepatology</subject></subj-group><subj-group subj-group-type="heading"><subject>Translational Medicine</subject></subj-group><subj-group subj-group-type="heading"><subject>Medical Genetics</subject></subj-group></article-categories><title-group><article-title>Selected Alu methylation levels in the gastric carcinogenesis cascade</article-title></title-group><contrib-group><contrib id="author-1" contrib-type="author" corresp="yes"><name><surname>Meevassana</surname><given-names>Jiraroch</given-names></name><xref rid="aff-1" ref-type="aff">1</xref><email>drjiraroch@gmail.com</email></contrib><contrib id="author-2" contrib-type="author"><name><surname>Vongsuly</surname><given-names>Chawisa Wanda</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib id="author-3" contrib-type="author"><name><surname>Nakbua</surname><given-names>Tanchanok</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib id="author-4" contrib-type="author"><name><surname>Kamolratanakul</surname><given-names>Supitcha</given-names></name><xref rid="aff-2" ref-type="aff">2</xref></contrib><contrib id="author-5" contrib-type="author"><name><surname>Thitiwanichpiwong</surname><given-names>Pichaya</given-names></name><xref rid="aff-3" ref-type="aff">3</xref></contrib><contrib id="author-6" contrib-type="author"><name><surname>Bin-Alee</surname><given-names>Fardeela</given-names></name><xref rid="aff-4" ref-type="aff">4</xref></contrib><contrib id="author-7" contrib-type="author"><name><surname>Keelawat</surname><given-names>Somboon</given-names></name><xref rid="aff-5" ref-type="aff">5</xref></contrib><contrib id="author-8" contrib-type="author" corresp="yes"><name><surname>Kitkumthorn</surname><given-names>Nakarin</given-names></name><xref rid="aff-6" ref-type="aff">6</xref><email>Nakarinkit@gmail.com</email></contrib><aff id="aff-1">
<label>1</label><institution>Center of Excellence in Burn and Wound Care, Faculty of Medicine, Chulalongkorn University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff-2">
<label>2</label><institution>Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff-3">
<label>3</label><institution>Digital Pathology Center, Siriraj Piyamaharajkarun Hospital, Mahidol University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff-4">
<label>4</label><institution>Faculty of Medicine, Princess of Naradhiwas University</institution>, <addr-line>Narathiwat</addr-line>, <country>Thailand</country></aff><aff id="aff-5">
<label>5</label><institution>Department of Pathology, Faculty of Medicine, Chulalongkorn University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff-6">
<label>6</label><institution>Department of Oral Biology, Faculty of Dentistry, Mahidol University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Felley-Bosco</surname><given-names>Emanuela</given-names></name></contrib></contrib-group><pub-date pub-type="epub"><day>20</day><month>5</month><year iso-8601-date="2025">2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>e19485</elocation-id><history><date date-type="received" iso-8601-date="2024-12-10"><day>10</day><month>12</month><year iso-8601-date="2024">2024</year></date><date date-type="accepted" iso-8601-date="2025-04-27"><day>27</day><month>4</month><year iso-8601-date="2025">2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Meevassana et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Meevassana et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions><self-uri xlink:href="https://peerj.com/articles/19485"/><abstract><sec><title>Background</title><p>Genome-wide hypomethylation, a common epigenetic change that occurs during cancer development, primarily affects repetitive elements, such as Alu repeats. Consequently, Alu repeats can be used as a surrogate marker of genomic hypomethylation.</p></sec><sec><title>Methods</title><p>In this study, we aimed to investigate the correlation between Alu methylation levels and the multistage course of gastric carcinogenesis.</p></sec><sec><title>Results</title><p>We found that the Alu methylation levels in gastric cancer tissue decreased compared with those in normal gastric tissue, with the change in methylation levels and pattern being most significant between chronic gastritis and intestinal metaplasia. Moreover, Alu methylation levels were not associated with <italic toggle="yes">Helicobacter pylori</italic> or Epstein&#x02013;Barr virus infection.</p></sec><sec><title>Conclusions</title><p>Finally, our sensitivity and specificity analyses suggested that Alu methylation level can be used to distinguish gastric cancer tissue from normal tissue. Thus, Alu methylation level shows promise as biomarker for gastric cancer diagnosis.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Hypomethylation</kwd><kwd><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd>Gastric cancer</kwd><kwd>Epstein&#x02013;Barr virus</kwd></kwd-group><funding-group><funding-statement>The authors received no funding for this work.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Despite recent reductions in the prevalence of gastric cancer (GC) and the associated death rate, GC continues to pose considerable health concerns worldwide. Currently, GC is the fifth most commonly reported malignancy and the third leading cause of cancer-related mortality globally (<xref rid="ref-61" ref-type="bibr">Thrift &#x00026; El-Serag, 2020</xref>). Early-stage GC is often asymptomatic or causes only non-specific symptoms; consequently, most patients present with advanced-stage cancer because of delayed diagnosis (<xref rid="ref-65" ref-type="bibr">Xia &#x00026; Aadam, 2022</xref>; <xref rid="ref-50" ref-type="bibr">Pasechnikov et al., 2014</xref>). Surgery is the only available radical treatment for GC (<xref rid="ref-60" ref-type="bibr">Song et al., 2017</xref>). However, the curative surgical window is often missed because of the late stages of diagnosis and dissemination, contributing to the poor prognosis of GC (<xref rid="ref-50" ref-type="bibr">Pasechnikov et al., 2014</xref>; <xref rid="ref-60" ref-type="bibr">Song et al., 2017</xref>; <xref rid="ref-30" ref-type="bibr">Kanda &#x00026; Kodera, 2015</xref>). Therefore, importance should be placed on early GC detection using effective screening approaches and the development of novel diagnostics to improve GC-related mortality.</p><p>Similar to all malignant tumors, early GC detection relies on understanding its multistep, multifactorial etiology and pathogenesis. Gastric adenocarcinomas, particularly the more prevalent intestinal type, follow a well-characterized sequence of histopathological transformations. This progression begins with normal gastric mucosa, advancing to non-atrophic chronic gastritis, followed by the development of multifocal atrophic gastritis, resulting in intestinal metaplasia, which may further evolve into gastric dysplasia, ultimately leading to the onset of gastric adenocarcinoma (<xref rid="ref-12" ref-type="bibr">Correa &#x00026; Piazuelo, 2012</xref>). <italic toggle="yes">Helicobacter pylori</italic> infection is the predominant cause of early gastritis and the onset of chronic gastritis, which are critical stages in the advancement of gastric carcinogenesis. Multiple environmental factors are involved in this complex process (<xref rid="ref-12" ref-type="bibr">Correa &#x00026; Piazuelo, 2012</xref>). Additionally, approximately 10% of GC cases can be attributed to Epstein&#x02013;Barr virus (EBV) infection (<xref rid="ref-43" ref-type="bibr">Naseem et al., 2018</xref>). Although the exact mechanisms remain unclear, evidence suggests that EBV induces extensive promoter hypermethylation (<xref rid="ref-61" ref-type="bibr">Thrift &#x00026; El-Serag, 2020</xref>; <xref rid="ref-43" ref-type="bibr">Naseem et al., 2018</xref>; <xref rid="ref-45" ref-type="bibr">Padmanabhan, Ushijima &#x00026; Tan, 2017</xref>; <xref rid="ref-46" ref-type="bibr">Palrasu et al., 2021</xref>; <xref rid="ref-40" ref-type="bibr">Matsusaka et al., 2014</xref>).</p><p>In addition to the histopathological and environmental factors, various genetic and epigenetic alterations underlie the gastric carcinogenesis cascade. Genetic contribution to tumorigenesis is comparatively uncomplicated. Mutations in tumor suppressor genes (TSGs) or oncogenes cause either loss or gain of function, respectively. To date, several GC-related oncogenes and TSGs have been reported (<xref rid="ref-30" ref-type="bibr">Kanda &#x00026; Kodera, 2015</xref>), including the oncogenes <italic toggle="yes">ERBB3</italic> and <italic toggle="yes">CCND1</italic> (<xref rid="ref-30" ref-type="bibr">Kanda &#x00026; Kodera, 2015</xref>; <xref rid="ref-56" ref-type="bibr">Shan et al., 2017</xref>) and the TSG <italic toggle="yes">p53</italic>, which occurs in over 60% of GCs (<xref rid="ref-59" ref-type="bibr">Smith et al., 2006</xref>). The epigenetic contribution to tumorigenesis is more elaborate than genetic contribution. Epigenetics is regulated by chromatin structure, which is controlled by various processes, including methylation, acetylation, phosphorylation, ubiquitylation, nucleosome remodeling, and regulation by non-coding regulatory RNAs (<xref rid="ref-4" ref-type="bibr">Baylin &#x00026; Jones, 2016</xref>). Epigenetic alterations can affect the expression of TSGs or oncogenes, leading to tumorigenesis (<xref rid="ref-4" ref-type="bibr">Baylin &#x00026; Jones, 2016</xref>).</p><p>Epigenetic changes that occur during carcinogenesis include promoter hypermethylation and global hypomethylation (<xref rid="ref-72" ref-type="bibr">You &#x00026; Jones, 2012</xref>). For example, a methyl group is added to the fifth carbon atom of the cytidine ring in a CpG dinucleotide sequence at the 5&#x02032; position. This modification plays a critical role in gene regulation and epigenetic control (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>). Promoter hypermethylation results in transcriptional silencing; when this alteration occurs in the promoter sequences, it contributes to carcinogenesis. On the contrary, genomic hypomethylation results in genomic or chromosomal instability (<xref rid="ref-1" ref-type="bibr">Bae et al., 2012</xref>). Genomic hypomethylation can occur <italic toggle="yes">via</italic> several pathways. One mechanism involves the passive loss or impaired function of DNA methyltransferase 1 (DNMT1). Alternatively, active demethylation can occur through the oxidation of methylated cytosines, catalyzed by ten-eleven translocation enzymes. Additionally, activation-induced deaminase (AID)-mediated deamination of methylcytosine, followed by base excision repair, represents another route for genomic hypomethylation (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>; <xref rid="ref-57" ref-type="bibr">Sheaffer, Elliott &#x00026; Kaestner, 2016</xref>).</p><p>A more in-depth explanation of Alu elements as epigenetic regulators and their impact on genomic instability, transcriptional regulation, and retrotransposon activity (<xref rid="ref-69" ref-type="bibr">Ye et al., 2020</xref>; <xref rid="ref-51" ref-type="bibr">Patchsung et al., 2018</xref>). Alterations in the methylation of Alu and have been shown to be associated with many cancer types, hepatoma, breast cancer, ovarian cancer, acute myeloid leukaemia, T-cell lymphoblastic leukaemia, Ewing sarcoma, and colorectal cancer (<xref rid="ref-73" ref-type="bibr">Y&#x000fc;ksel et al., 2016</xref>; <xref rid="ref-29" ref-type="bibr">Jord&#x000e0; et al., 2017</xref>; <xref rid="ref-48" ref-type="bibr">Park et al., 2014</xref>; <xref rid="ref-5" ref-type="bibr">Belancio, Deininger &#x00026; Roy-Engel, 2009</xref>; <xref rid="ref-10" ref-type="bibr">Chenais, 2015</xref>; <xref rid="ref-70" ref-type="bibr">Yooyongsatit et al., 2013</xref>). Alu hypomethylation may disrupt heterochromatin structure, leading to a more open chromatin conformation (<xref rid="ref-3" ref-type="bibr">Baylin et al., 2001</xref>; <xref rid="ref-32" ref-type="bibr">Kim, 2019</xref>). This loss of chromatin compaction can impair genome stability by making DNA more susceptible to damage and reducing the efficiency of DNA repair mechanisms (<xref rid="ref-17" ref-type="bibr">Grewal &#x00026; Jia, 2007</xref>). Furthermore, reduced heterochromatin formation may result in aberrant activation of normally silenced genomic regions, increasing transcriptional noise and promoting inappropriate gene expression. These changes can ultimately contribute to genomic instability and tumorigenesis by facilitating mutations, recombination events, and disruption of normal replication and transcription regulation (<xref rid="ref-67" ref-type="bibr">Xu, Xu &#x00026; Price, 2012</xref>; <xref rid="ref-24" ref-type="bibr">Jakob et al., 2011</xref>; <xref rid="ref-11" ref-type="bibr">Chevalier et al., 2025</xref>). Alu elements play a multifaceted role in cancer development through mechanisms involving epigenetic regulation, genomic instability, and RNA interference. Under normal physiological conditions, Alu sequences are heavily methylated to suppress their transpositional activity and maintain genomic stability (<xref rid="ref-7" ref-type="bibr">Bhat et al., 2022</xref>). However, in various malignancies such as gastric, colorectal, and lung cancers, global DNA hypomethylation leads to increased Alu activity (<xref rid="ref-69" ref-type="bibr">Ye et al., 2020</xref>). This reactivation results in insertional mutagenesis, deletions, and chromosomal rearrangements, thereby contributing to genomic instability and cancer progression (<xref rid="ref-51" ref-type="bibr">Patchsung et al., 2018</xref>; <xref rid="ref-13" ref-type="bibr">Ehrlich, 2009</xref>; <xref rid="ref-35" ref-type="bibr">Li et al., 2025</xref>; <xref rid="ref-44" ref-type="bibr">Oomen et al., 2025</xref>). Beyond their role in genome structure, Alu elements also influence gene expression through transcriptional regulation (<xref rid="ref-25" ref-type="bibr">Jayaraman et al., 2025</xref>). They contain transcription factor binding sites, and when positioned near oncogenes or tumor suppressor genes, they can modulate gene transcription, often promoting uncontrolled cellular proliferation (<xref rid="ref-29" ref-type="bibr">Jord&#x000e0; et al., 2017</xref>; <xref rid="ref-10" ref-type="bibr">Chenais, 2015</xref>; <xref rid="ref-3" ref-type="bibr">Baylin et al., 2001</xref>; <xref rid="ref-17" ref-type="bibr">Grewal &#x00026; Jia, 2007</xref>). For instance, Alu sequences have been shown to affect the activity of the tumor suppressor p53 in several cancer models (<xref rid="ref-2" ref-type="bibr">Bao et al., 2017</xref>; <xref rid="ref-52" ref-type="bibr">Pfeifer, 2000</xref>; <xref rid="ref-39" ref-type="bibr">Mangoni et al., 2025</xref>). Furthermore, Alu elements are involved in RNA-based regulatory pathways by giving rise to non-coding RNAs, including Alu-derived microRNAs such as miR-23a. These miRNAs regulate genes implicated in cell cycle progression, apoptosis, and immune responses within cancerous tissues. Accumulation of Alu RNAs can also activate inflammatory pathways, such as NF-&#x003ba;B signaling, thereby contributing to the remodeling of the tumor microenvironment (<xref rid="ref-64" ref-type="bibr">Wang et al., 2018</xref>; <xref rid="ref-33" ref-type="bibr">Lee &#x00026; Dutta, 2009</xref>). Due to their enrichment in gene-dense genomic regions, Alu elements serve as potential hotspots for tumorigenic mutations (<xref rid="ref-18" ref-type="bibr">Gu et al., 2016</xref>). Their deregulation, particularly through hypomethylation, underscores their significant role in the early stages of tumorigenesis.</p><p>Genome-wide methylation mainly affects repetitive elements such as Alu repeats, LINE-1, satellite-&#x003b1; (SAT&#x003b1;), and juxtacentromeric satellite 2 sequences (SAT2) (<xref rid="ref-13" ref-type="bibr">Ehrlich, 2009</xref>). Alu repeats are short interspersed elements (SINEs) considered to be derived from the 7SL RNA gene (<xref rid="ref-31" ref-type="bibr">Khitrinskaya, Stepanov &#x00026; Puzyrev, 2003</xref>). Alu elements are the most common SINEs in humans, with more than a million copies distributed throughout the genome, comprising 10% of the genetic material. They are predominantly distributed in gene-rich regions (<xref rid="ref-31" ref-type="bibr">Khitrinskaya, Stepanov &#x00026; Puzyrev, 2003</xref>). Therefore, Alu markers can be used as representative markers of global methylation levels. Notably, diseases reportedly linked to alterations in Alu or LINE-1 methylation include hereditary diseases such as facioscapulohumeral muscular dystrophy syndrome, ataxia telangiectasia, and Aicardi-Gouti&#x000e8;res (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>; <xref rid="ref-21" ref-type="bibr">Himeda &#x00026; Jones, 2019</xref>); disorders caused by the immune system including diabetes type 1, rheumatoid arthritis, and systemic lupus erythematosus (<xref rid="ref-36" ref-type="bibr">Li et al., 2021</xref>; <xref rid="ref-19" ref-type="bibr">Hedrich et al., 2017</xref>); neurologic diseases including autism spectrum disorders, Alzheimer&#x02019;s disease, and major depressive disorder (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>; <xref rid="ref-62" ref-type="bibr">Tremblay &#x00026; Jiang, 2019</xref>; <xref rid="ref-8" ref-type="bibr">Bollati et al., 2011</xref>); burn scars (<xref rid="ref-42" ref-type="bibr">Meevassana et al., 2022</xref>); as well as cancer and aging (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>; <xref rid="ref-37" ref-type="bibr">Luo, Lu &#x00026; Xie, 2014</xref>).</p><p>The aim of this study was to analyze the relationship between global DNA methylation levels and the advancing phases of gastric carcinogenesis. We investigated the temporal dynamics of global hypomethylation during gastric carcinogenesis. We examined Alu methylation levels at different stages of this process by comparing the methylation profiles across normal gastric (NS), chronic gastritis (CG), intestinal metaplasia (IM), gastric dysplasia (GD), and gastric adenocarcinoma (GA) tissues. Moreover, we evaluated whether <italic toggle="yes">H. pylori</italic> and EBV infections affected global hypomethylation during the carcinogenesis cascade. Furthermore, we determined the sensitivity of Alu methylation level in detecting early GA. We anticipate that the findings of this study will enhance our understanding of epigenetic mechanisms involved in GC pathogenesis. Moreover, we aimed to assess the potential of Alu methylation as a reliable biomarker for the early detection of GA. If proven effective, these measurements may offer a non-invasive alternative to traditional biopsy and histopathological examination in future clinical practice.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Study design, sample size, and population</title><p>Formalin-fixed paraffin-embedded (FFPE) biopsied specimens were obtained from 14 patients with NS, 32 with CG, 36 with IM, 15 with GD, and 29 with GA at the Pathological Department, Faculty of Medicine, Chulalongkorn University between January 2022 and January 2023 (<xref rid="table-1" ref-type="table">Table 1</xref>). Samples were collected from patients who had undergone primary endoscopic biopsy and had not taken any medications that could suppress <italic toggle="yes">H</italic>. pylori infection. A histopathological review by Somboon Keelawat of the natural killer cells was conducted to confirm the diagnosis. The exclusion criteria included limited amounts of pathological tissue, lack of clinical data, and poor DNA quality.</p><table-wrap position="float" id="table-1"><object-id pub-id-type="doi">10.7717/peerj.19485/table-1</object-id><label>Table 1</label><caption><title>Alu methylation in gastric carcinogenesis tissue cascade.</title></caption><alternatives><graphic xlink:href="peerj-13-19485-g004" position="float"/><table frame="hsides" rules="groups" content-type="text"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">No</th><th rowspan="1" colspan="1">Sex (male, female)</th><th rowspan="1" colspan="1">Age (median, range; y)</th><th rowspan="1" colspan="1"><italic toggle="yes">H. pylori</italic> infection (positive, negative)</th><th rowspan="1" colspan="1">EBV infection (positive, negative)</th><th rowspan="1" colspan="1">Alu methylation (Avg., SD; %)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Normal stomach (NS)</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">6, 8</td><td rowspan="1" colspan="1">53, 5, 18&#x02013;93</td><td rowspan="1" colspan="1">1, 13</td><td rowspan="1" colspan="1">0, 14</td><td rowspan="1" colspan="1">43.51, 3.18</td></tr><tr><td rowspan="1" colspan="1">Chronic gastritis (CG)</td><td rowspan="1" colspan="1">32</td><td rowspan="1" colspan="1">15, 17</td><td rowspan="1" colspan="1">64, 31&#x02013;81</td><td rowspan="1" colspan="1">13, 19</td><td rowspan="1" colspan="1">0, 32</td><td rowspan="1" colspan="1">44.58, 2.45</td></tr><tr><td rowspan="1" colspan="1">Intestinal metaplasia (IM)</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">15, 21</td><td rowspan="1" colspan="1">62, 22&#x02013;85</td><td rowspan="1" colspan="1">9, 27</td><td rowspan="1" colspan="1">0, 36</td><td rowspan="1" colspan="1">39.09, 1.98</td></tr><tr><td rowspan="1" colspan="1">Gastric dysplasia (GD)</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">7, 8</td><td rowspan="1" colspan="1">72, 49&#x02013;92</td><td rowspan="1" colspan="1">0, 15</td><td rowspan="1" colspan="1">0, 15</td><td rowspan="1" colspan="1">41.66, 4.04</td></tr><tr><td rowspan="1" colspan="1">Gastric adenocarcinoma (GA)</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">8, 21</td><td rowspan="1" colspan="1">68, 27&#x02013;94</td><td rowspan="1" colspan="1">8, 21</td><td rowspan="1" colspan="1">4, 25</td><td rowspan="1" colspan="1">38.79, 1.78</td></tr></tbody></table></alternatives></table-wrap></sec><sec><title>Ethics declaration</title><p>This study was approved by the Review Committee of the Medical Faculty of Chulalongkorn University in Bangkok, Thailand (IRB number 544/64, COA code 983/2021). All procedures were conducted according to the principles of the Declaration of Helsinki (1975) with the latest amendments from 2013. Written informed consent was obtained from the participants before enrollment. To ensure the protection of personal data, all samples and clinical information were anonymized and coded. Access to identifiable data was restricted to authorized personnel only, and all data were stored securely in protected databases.</p></sec><sec><title>Microscopic analysis</title><p>The biopsy specimens were fixed in 10% neutral formalin solution. Thereafter, the specimens were embedded in paraffin and cut into 2-&#x000b5;m-thick sections. The sections were subsequently subjected to hematoxylin and eosin (H&#x00026;E) staining for microscopic examination.</p></sec><sec><title>Giemsa staining for <italic toggle="yes">H. pylori</italic></title><p>In addition to the H&#x00026;E-stained slides used for microscopic analysis, a separate slide was stained with Giemsa stain to detect <italic toggle="yes">H. pylori</italic>. Briefly, thin slices of the specimens were carefully placed on dry, clean, microscopic glass slides. After deparaffinization, the slides were hydrated with distilled water. A mixture of Giemsa staining solution, distilled water (1:20 ratio), and 12.5% methanol was used to prepare <italic toggle="yes">H. pylori</italic> solution. The sections were then incubated in the <italic toggle="yes">H. pylori</italic> solution for 15&#x02013;30 min. Glass covers were placed over the slides, and the presence of <italic toggle="yes">H. pylori</italic> was determined based on the observation of curved rods. Histological assessment was performed by two pathologists (SK and NK) who were blinded to the clinical data and endoscopic findings.</p></sec><sec><title><italic toggle="yes">In situ</italic> hybridization for EBV</title><p>We assessed EBV using <italic toggle="yes">in situ</italic> hybridization (ISH) to detect EBER. The EBER-ISH procedure was conducted on 2-&#x000b5;m-thick FFPE histological sections. Briefly, tissue sections were stained using an EBV probe/antibody ISH kit (Leica, Newcastle upon Tyne, UK) in conjunction with a Ventana Benchmark XT automated slide stainer (Roche, Tucson, AZ, USA). To enhance the staining process, an Ultra Vision Large Volume Detection System Anti-Polyvalent HRP (Thermo Fisher Scientific, Waltham, MA, USA) was used according to the manufacturer&#x02019;s instructions. Hybridization signals were visualized through a reaction with the ImmPACT&#x02122; DAB Peroxidase Substrate (Vector Laboratories, Burlingame, CA, USA). After staining, the sections were dehydrated with ethanol and xylene and subsequently mounted using suitable mounting medium.</p></sec><sec><title>DNA extraction and bisulfite modification</title><p>FFPE samples were cut into 2-&#x000b5;m-thick sections using a microtome (Microm HM355S; Thermo Fisher Scientific, Walldorf, Germany). The sections were then deparaffinized with xylene. Genomic DNA was extracted using 10% sodium dodecyl sulfate (SDS) (Thermo Fisher Scientific, Fremont, CA, USA) lysis buffer to disrupt cell membranes, coupled with proteinase K enzymatic digestion to degrade proteins and ensure the release of high-quality nucleic acids. This process was followed by a conventional phenol/chloroform extraction method, which effectively separates DNA from proteins and other cellular contaminants. After extraction, the genomic DNA was quantitatively examined using a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). The integrity and suitability of the DNA for downstream applications were confirmed using spectrophotometric analysis, which allowed for an accurate assessment of the absorbance at 260/280 and 260/230 nm. This evaluation ensured minimal contamination with proteins and organic compounds.</p><p>Following DNA extraction, 500 ng of the purified genomic DNA was bisulfite-converted using an EZ DNA Methylation-Gold&#x02122; kit (Zymo Research, Irvine, CA, USA) according to the manufacturer&#x02019;s guidelines. Bisulfite treatment promotes the deamination of unmethylated cytosine bases, transforming them into uracil. This biochemical alteration enabled precise methylation-specific assays for subsequent analyses. The high efficiency of this conversion process is critical for accurate epigenetic studies, including DNA methylation profiling, in biomedical and genetic research. This method ensures the preservation of methylated cytosines, enabling precise downstream applications such as methylation-specific polymerase chain reaction (PCR) and bisulfite sequencing (<xref rid="ref-51" ref-type="bibr">Patchsung et al., 2018</xref>; <xref rid="ref-70" ref-type="bibr">Yooyongsatit et al., 2013</xref>; <xref rid="ref-42" ref-type="bibr">Meevassana et al., 2022</xref>; <xref rid="ref-55" ref-type="bibr">Prucksakorn et al., 2025</xref>; <xref rid="ref-28" ref-type="bibr">Jiraboonsri et al., 2024</xref>).</p></sec><sec><title>COBRA</title><p>After bisulfite conversion of DNA, the methylation status of the CpG located within the Alu repetitive sequences was assessed <italic toggle="yes">via</italic> PCR. The amplification process began with denaturation at 95 &#x000b0;C for 15 min, followed by 35 cycles of denaturation at 95 &#x000b0;C for 45 s, annealing at 57 &#x000b0;C for 45 s, and extension at 72 &#x000b0;C for 45 s. The extension step at 72 &#x000b0;C for 15 min facilitated the synthesis of the PCR products. The primers utilized in this reaction included the following: forward 5&#x02032;-GGYGUGGTGGTTTAYGTTTGTAA-3&#x02032; and reverse 5&#x02032;-CTAACTTTTTATATTTTTAATAAAAACRAAATTTCACCA-3&#x02032;. The primers were developed using the Alu repetitive sequence obtained from GenBank (NM_031483.7). These sequences have undergone prior validation and have been effectively utilized in our investigations to ensure the precise analysis of CpG methylation (<xref rid="ref-55" ref-type="bibr">Prucksakorn et al., 2025</xref>; <xref rid="ref-28" ref-type="bibr">Jiraboonsri et al., 2024</xref>).</p><p>Examining Alu methylation patterns is important for understanding the pathogenesis of various conditions, including cancer, aging-related processes, and other genetic disorders. Such studies will contribute to elucidating how epigenetic modifications affect genomic stability and gene regulation. Following PCR amplification, the PCR products were cut using a TaqI restriction enzyme (Thermo Fisher Scientific, Waltham, MA, US), with the reaction performed under optimal conditions at 65 &#x000b0;C for 16 h (<xref rid="ref-51" ref-type="bibr">Patchsung et al., 2018</xref>; <xref rid="ref-70" ref-type="bibr">Yooyongsatit et al., 2013</xref>; <xref rid="ref-42" ref-type="bibr">Meevassana et al., 2022</xref>; <xref rid="ref-55" ref-type="bibr">Prucksakorn et al., 2025</xref>; <xref rid="ref-28" ref-type="bibr">Jiraboonsri et al., 2024</xref>). After digestion, the samples were subjected to gel electrophoresis using an 8% non-denaturing polyacrylamide gel to resolve the digested fragments based on their size. The resulting DNA fragments were visualized by staining the gel with SYBR Green (Lonza Group, Ltd., Basel, Switzerland) for 30 min; SYBR Green binds to nucleic acids and enable fluorescence-based detection. The DNA band intensity was quantitatively measured using Strom840 imaging and ImageQuant NT software (Amersham; Cytiva, Marlborough, MA, USA) to assess the degree of methylation based on the band patterns. For quality assurance and reliability of the agarose gel electrophoresis and subsequent band intensity analysis, DNA extracted from HeLa cells was used as a positive control to confirm the accuracy of agarose gel electrophoresis and band intensity quantification. As a negative control, a full reaction mixture with all reagents except DNA, to ensure there was no contamination or non-specific enzymatic activity during the assay. COBRA assays were performed in duplicate to ensure technical consistency, following the approach used in our previous study (<xref rid="ref-42" ref-type="bibr">Meevassana et al., 2022</xref>; <xref rid="ref-9" ref-type="bibr">Chaiwongkot et al., 2022</xref>; <xref rid="ref-41" ref-type="bibr">Meevassana et al., 2022</xref>).</p></sec><sec><title>Alu methylation analysis</title><p>The COBRA technique assesses DNA methylation patterns by analyzing band lengths associated with different CpG locus configurations. These patterns were categorized by methylation status at the two CpG sites within the Alu elements. Specifically, Alu sequences can exhibit the following patterns: two unmethylated CpG sites (denoted as uCuC), which produce a band of 133 base pairs (bp); two fully methylated CpGs (mCmC), resulting in bands of 58 and 32 bp; 1 uCmC, forming a 75 bp band; and 1 mCuC, yielding a 90-bp band. This method is particularly useful for distinguishing the methylation status across multiple CpG sites, providing valuable insights into epigenetic regulation within repetitive elements such as Alu sequences. Variation in band length correlates directly with specific methylation patterns, which is critical for understanding the functional consequences of DNA methylation in genomic regulation and disease. To quantify the intensity of each electrophoretic band, the intensity measured for each band was normalized by dividing it with the corresponding band length. Specific calculations for each band were as follows: (A) 133 bp divided by 133; (B) 58 bp divided by 58; (C) 75 bp divided by 73; (D) 90 bp divided by 90; and (E) 43 bp divided by 41. Subsequently, the methylation status of the Alu loci was determined using several formulas and expressed as percentage. The overall Alu methylation level, denoted as %mC, was calculated using the following formula: %mC = 100 &#x000d7; (B + E)/(2A + B + C + D + E). Further classification of the methylation status at specific loci involved determining the percentage of loci that were fully methylated at both CpG sites (%mCmC), hemimethylated at one CpG site (%uCmC and %mCuC), or fully unmethylated (%uCuC). To calculate the percentage contribution of each component within a system, we followed a similar approach for each component by determining its value relative to the total sum of all components (A, C, D, and F).</p><p>The percentage of mCmC was determined by dividing the value of component F by the sum of all components (A, C, D, and F) and then converting this fraction into a percentage. The percentage of mCmC was calculated as (F/(A + C + D + F)) &#x000d7; 100.</p><p>For uCmC, we calculated the percentage by dividing the value of component C by the total sum of all components and then converting that value into a percentage. The percentage of uCmC was determined as follows: (C/(A + C + D + F)) &#x000d7; 100.</p><p>To determine the percentage of mCuC, the value of component D was divided by the total of all components and converted into a percentage. The percentage of mCuC was computed as (D/(A + C + D + F)) &#x000d7; 100.</p><p>Finally, the percentage of uCuC was calculated by dividing the value of component A with the total sum of all components and converting the result into a percentage. The percentage of uCuC is calculated as (A/(A + C + D + F)) &#x000d7; 100.</p><p>Each step allowed the expression of the proportion of a specific component as a percentage of the total, ensuring that the contribution of each component was accurately represented in relation to the entire system.</p><p>These detailed calculations enabled an in-depth analysis of the epigenetic status of Alu repetitive elements, which serve as important markers for genome-wide methylation profiling in biomedical and genetic research.</p></sec><sec><title>Statistical analysis</title><p>In this study, we examined global Alu methylation levels and their specific patterns across NS, CG, IM, GD, and GA cohorts. The Kruskal&#x02013;Wallis test was used to assess differences between groups. Pairwise comparisons using Tukey&#x02019;s <italic toggle="yes">post-hoc</italic> analysis were used to further investigate intergroup differences. The multivariate regression analysis was used to confirm the independent association between Alu methylation and pathological stages. The diagnostic performance of global Alu methylation was analyzed using ROC curve analysis, AUC, specificity, and sensitivity. Statistical analyses were performed using SPSS software (version 25.0; SPSS Inc., Chicago, IL, USA). Statistical significance was considered at <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Alu methylation levels along the carcinogenesis cascade</title><p>The Alu methylation levels (mC) showed a significant reduction (<italic toggle="yes">p</italic> &#x0003c; 0.0001) from NS and CG to IM and GA (<xref rid="table-1" ref-type="table">Table 1</xref> and <xref rid="fig-1" ref-type="fig">Fig. 1A</xref>). Differences in the mC pattern of Alu methylation were observed between CG and IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), CG and GA (<italic toggle="yes">p</italic> &#x0003c; 0.0001), NS and IM (<italic toggle="yes">p</italic> = 0.0007), and NS and GA (<italic toggle="yes">p</italic> = 0.007). Detailed frequency data are listed in <xref rid="supp-2" ref-type="supplementary-material">Table S1</xref>. As shown in <xref rid="fig-1" ref-type="fig">Fig. 1B</xref>, the mCmC pattern of Alu methylation was compared between CG and IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), CG and GA (<italic toggle="yes">p</italic> = 0.0058), NS and IM (<italic toggle="yes">p</italic> = 0.0002), and IM and GD (<italic toggle="yes">p</italic> = 0.0216).</p><fig position="float" id="fig-1"><object-id pub-id-type="doi">10.7717/peerj.19485/fig-1</object-id><label>Figure 1</label><caption><title>Alu methylation patterns across sample groups.</title><p>(A) The overall Alu methylation (mC) decreased significantly from NS and CG to IM and GA (<italic toggle="yes">p</italic> &#x0003c; 0.0001) for these comparisons. (B) Significant differences in mCmC Alu methylation were observed between CG and IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), NS and IM (<italic toggle="yes">p</italic> = 0.0002), CG and GA (<italic toggle="yes">p</italic> = 0.0058), and IM and GD (<italic toggle="yes">p</italic> = 0.0216). (C) The mCuC methylation pattern also significantly differed between CG and IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), NS and GA (<italic toggle="yes">p</italic> = 0.0348), CG and GA (<italic toggle="yes">p</italic> = 0.0008), and IM and GA (<italic toggle="yes">p</italic> = 0.0258). (D) A notable increase in uCmC Alu methylation was observed in IM compared with that in CG (<italic toggle="yes">p</italic> &#x0003c; 0.0001), GD (<italic toggle="yes">p</italic> = 0.0100), and GA (<italic toggle="yes">p</italic> = 0.0029). (E) In contrast to other patterns, the frequency of uCuC Alu methylation progressively increased from NS to CG, GD, and GA, with differences found between NS and GA (<italic toggle="yes">p</italic> &#x0003c; 0.0001), CG and GA (<italic toggle="yes">p</italic> = 0.0002), IM and GA (<italic toggle="yes">p</italic> = 0.0134), and GD and GA (<italic toggle="yes">p</italic> = 0.0085). NS, normal gastric tissue; CG, chronic gastritis; IM, intestinal metaplasia; GD, gastric dysplasia; GA, gastric adenocarcinoma. *<italic toggle="yes">p</italic> &#x0003c; 0.05, **<italic toggle="yes">p</italic> &#x0003c; 0.01, ***<italic toggle="yes">p</italic> &#x0003c; 0.001 and ****<italic toggle="yes">p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="peerj-13-19485-g001" position="float"/></fig><p>The mCuC pattern of Alu methylation showed significant differences among the CG:IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), NS:GA (<italic toggle="yes">p</italic> = 0.0348), CG:GA (<italic toggle="yes">p</italic> = 0.0008), and IM:GA (<italic toggle="yes">p</italic> = 0.0258) groups (<xref rid="fig-1" ref-type="fig">Fig. 1C</xref>). Moreover, the uCmC pattern of Alu methylation considerably increased in the IM group. The uCmC pattern of Alu methylation also significantly differed among the CG:IM (<italic toggle="yes">p</italic> &#x0003c; 0.0001), IM:GD (<italic toggle="yes">p</italic> = 0.0100), and IM:GA (<italic toggle="yes">p</italic> = 0.0029) groups, as shown in <xref rid="fig-1" ref-type="fig">Fig. 1D</xref>.</p><p>In contrast to the other patterns, the uCuC pattern of Alu methylation increased from NS to CG, GD, and GA. Significant differences were found among the NS:GA (<italic toggle="yes">p</italic> &#x0003c; 0.0001), CG:GA (<italic toggle="yes">p</italic> = 0.0002), IM:GA (<italic toggle="yes">p</italic> = 0.0134), and GD:GA (<italic toggle="yes">p</italic> = 0.0085) groups (<xref rid="fig-1" ref-type="fig">Fig. 1E</xref>).</p></sec><sec><title>The influence of sex and age on Alu methylation across different stages of gastric carcinogenesis</title><p>We performed a multivariate regression analysis adjusting for age and sex to assess their potential influence on the percentage of Alu methylation across different stages of gastric carcinogenesis. The results showed that neither sex nor age was significantly associated with the percentage of Alu methylation in normal stomach, chronic gastritis, intestinal metaplasia, dysplasia, or adenocarcinoma (<italic toggle="yes">p</italic> &#x0003e; 0.05 for all comparisons). However, the percentage of mCmC methylation in adenocarcinoma was significantly associated with sex (Adjusted &#x003b2; = &#x02212;4.09, 95% CI [&#x02212;8.16 to &#x02212;0.022], <italic toggle="yes">p</italic> = 0.049), and uCuC methylation was significantly associated with age (Adjusted &#x003b2; = &#x02212;0.060, 95% CI [&#x02212;0.10 to &#x02212;0.017], <italic toggle="yes">p</italic> = 0.008). All statistical results are shown in <xref rid="supp-2" ref-type="supplementary-material">Tables S2</xref>&#x02013;<xref rid="supp-2" ref-type="supplementary-material">S6</xref>.</p></sec><sec><title>Alu methylation and the influence of <italic toggle="yes">H. pylori</italic> and EBV infections</title><p>Based on Giemsa staining, a significant prevalence of <italic toggle="yes">H. pylori</italic> was observed in the CG group (40.63%), followed by the GA (27.59%), IM (25.00%), and NS (7.14%) groups. Notably, all 15 cases of GD showed absence of <italic toggle="yes">H. pylori</italic>. Based on EBV-encoded small RNA (EBER) analysis results, positive EBER staining was detected in 4 out of 25 cases (16%) of GA. Conversely, all remaining lesions and normal stomachs exhibited negative EBER staining. The results are summarized in <xref rid="table-1" ref-type="table">Table 1</xref>.</p><p>The Alu methylation levels in CG samples were comparable between <italic toggle="yes">H. pylori</italic>-negative and -positive samples, with percentages of 44.73 &#x000b1; 2.88% and 44.36 &#x000b1; 1.87%, respectively (<xref rid="supp-2" ref-type="supplementary-material">Table S1</xref>). However, in IM samples, the Alu methylation levels increased in <italic toggle="yes">H. pylori-</italic>negative samples compared with those in <italic toggle="yes">H. pylori-</italic>positive samples, although the difference was not significant (39.31 &#x000b1; 2.04% and 38.51 &#x000b1; 1.79%, respectively, <xref rid="fig-2" ref-type="fig">Fig. 2A</xref>). Similarly, in GA samples, the methylation levels in <italic toggle="yes">H. pylori</italic>-negative and -positive samples were 38.76 &#x000b1; 1.88% and 38.88 &#x000b1; 1.58%, respectively (<xref rid="fig-2" ref-type="fig">Fig. 2B</xref>).</p><fig position="float" id="fig-2"><object-id pub-id-type="doi">10.7717/peerj.19485/fig-2</object-id><label>Figure 2</label><caption><title>Alu methylation levels in relation to <italic toggle="yes">Helicobacter pylori</italic> and Epstein&#x02013;Barr virus (EBV) infections.</title><p>(A) Alu methylation in CG samples was similar between <italic toggle="yes">H. pylori</italic>-negative and -positive cases (44.73 &#x000b1; 2.88% <italic toggle="yes">vs</italic>. 44.36 &#x000b1; 1.87%, respectively), whereas, in IM samples, <italic toggle="yes">H. pylori</italic>-negative cases showed higher methylation levels than positive cases, though not statistically significant (39.31 &#x000b1; 2.04% <italic toggle="yes">vs</italic>. 38.51 &#x000b1; 1.79%). (B) In GA samples, Alu methylation between <italic toggle="yes">H. pylori</italic>-negative (38.76 &#x000b1; 1.88%) and -positive (38.88 &#x000b1; 1.58%) cases did not significantly differ. (C) EBV-encoded small RNA (EBER)-positive GA cases exhibited slightly higher Alu methylation levels than EBER-negative cases (39.24 &#x000b1; 1.49% and 38.72 &#x000b1; 1.88%, respectively), but the difference was not significant. NS, normal gastric tissue; CG, chronic gastritis; IM, intestinal metaplasia; GD, gastric dysplasia; GA, gastric adenocarcinoma.</p></caption><graphic xlink:href="peerj-13-19485-g002" position="float"/></fig><p>In relation to EBV infection, individuals with EBER-positive GA exhibited a slightly higher level of Alu methylation than those with EBER-negative GA. However, this difference was not significant (39.24 &#x000b1; 1.49% and 38.72 &#x000b1; 1.88%, respectively, as shown in <xref rid="fig-2" ref-type="fig">Fig. 2C</xref>).</p></sec><sec><title>Alu methylation levels as an additional marker for early GA detection</title><p>We assessed the efficacy of Alu methylation in detecting GA in biopsy lesions. In some cases, the gastric biopsy specimen was distorted or contained a small number of tumor cells. To address this issue, we carefully selected the most significant data points (NS + CG/GA, <italic toggle="yes">p</italic> &#x0003c; 0.0001; <xref rid="fig-3" ref-type="fig">Fig. 3A</xref>) to develop a test. To determine the optimal cut-off value, we employed receiver operating characteristic (ROC) curve analysis and subsequently calculated the sensitivity, specificity, and area under the curve (AUC). As shown in <xref rid="fig-3" ref-type="fig">Fig. 3B</xref>, the AUC of Alu methylation levels yielded a maximum value of 0.9344. Using methylation below 40.98% as the cut-off point, the analysis revealed 86.21% and 86.96% sensitivity and specificity, respectively.</p><fig position="float" id="fig-3"><object-id pub-id-type="doi">10.7717/peerj.19485/fig-3</object-id><label>Figure 3</label><caption><title>Diagnostic efficacy of Alu methylation levels in detecting GA from biopsy lesions.</title><p>(A) Alu methylation levels were significantly reduced in gastric adenocarcinoma (GA; <italic toggle="yes">n</italic> = 29) compared to non-cancerous tissues, including normal gastric tissue and chronic gastritis (NS + CG; <italic toggle="yes">n</italic> = 46), with a highly significant difference (<italic toggle="yes">p</italic> &#x0003c; 0.0001). These data suggest that Alu hypomethylation is associated with malignant transformation in gastric tissue. (B) Receiver operating characteristic (ROC) analysis demonstrated that Alu methylation has strong diagnostic potential for gastric adenocarcinoma (GA), with an AUC of 0.9344. Using a cut-off value of 40.98%, the assay achieved 86.21% sensitivity and 86.96% specificity. These findings highlight Alu methylation as a promising biomarker for the accurate detection of GA, even in biopsy samples with limited tumor content. ****<italic toggle="yes">p</italic> &#x0003c; 0.0001.</p></caption><graphic xlink:href="peerj-13-19485-g003" position="float"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Carcinogenesis is driven by both genetic and epigenetic alterations, and genome-wide hypomethylation is a common epigenetic change in cancer. Genome-wide hypomethylation mainly affects repetitive DNA sequences such as Alu repeats, LINE-1, SAT&#x003b1;, and SAT2. Therefore, repetitive elements may serve as representative genomic hypomethylation markers (<xref rid="ref-68" ref-type="bibr">Yang et al., 2004</xref>). Our study demonstrates a correlation between Alu methylation levels and GC progression.</p><p>The gradual reduction in Alu methylation observed from NS through CG, IM, GD, and GA indicates a progressive epigenetic modification associated with GC pathogenesis. The substantial differences in Alu methylation level between CG and both IM and GA suggest that this alteration is integral to the transformation from a chronic inflammatory state to a precancerous state and, eventually, malignancy. Furthermore, the differences among NS, IM, and GA indicate that epigenetic shifts start with disease progression, potentially before histological changes become apparent. These results indicate that Alu methylation can be used as a biomarker for diagnosing, investigating, and monitoring gastric disease progression, offering potential insights into disease pathogenesis and therapeutic strategies. Therefore, in-depth research is required to explore the methylation process and its contribution to GC development. Dual assessment of both methylation levels and patterns, acknowledging the heterogeneous nature of Alu methylation changes. Rather than using conventional pyrosequencing, we employed the COBRA-Alu method. Although COBRA analyzes fewer CpG sites than pyrosequencing, it offers comparable accuracy in determining methylation percentages (<xref rid="ref-27" ref-type="bibr">Jintaridth &#x00026; Mutirangura, 2010</xref>; <xref rid="ref-53" ref-type="bibr">Pobsook et al., 2011</xref>). Additionally, COBRA-Alu yields valuable insights by distinguishing between fully methylated, fully unmethylated, and two distinct partially methylated patterns. This enables a more nuanced analysis of methylation status, offering advantages over pyrosequencing, which is unable to differentiate among mCmC, uCmC, mCuC, and uCuC configurations (<xref rid="ref-26" ref-type="bibr">Jeddi et al., 2024</xref>). For the Alu methylation patterns (mCmC, uCmC, and mCuC), the most pronounced variation was observed between CG and intestinal IM.</p><p>Global DNA hypomethylation, particularly within repetitive elements such as Alu and LINE-1, is a hallmark of various malignancies, including gastric cancer (<xref rid="ref-16" ref-type="bibr">Gezer et al., 2024</xref>). In our study, Alu hypomethylation was significantly associated with the progression of gastric lesions, supporting its role as an early epigenetic event in gastric carcinogenesis. Hypomethylation leads to derepression of normally silenced retrotransposable elements, such as Alu and LINE-1, which are abundant in gene-rich regions. This can result in insertional mutagenesis, recombination events, and chromosomal instability&#x02014;mechanisms that contribute to the disruption of genomic integrity and facilitate malignant transformation (<xref rid="ref-66" ref-type="bibr">Xiang et al., 2010</xref>; <xref rid="ref-6" ref-type="bibr">Besselink et al., 2023</xref>). Furthermore, global hypomethylation has been implicated in the dysregulation of tumor suppressor genes (TSGs) through indirect mechanisms. Although TSG silencing is more commonly attributed to promoter hypermethylation, hypomethylation-induced genomic instability may lead to structural alterations, mutations, or deletions in TSG loci such as <italic toggle="yes">TP53</italic> and <italic toggle="yes">CDKN2A</italic>, other gastric cancer-related tumor suppressor genes such as <italic toggle="yes">CDH1</italic>, <italic toggle="yes">RASSF1A</italic>, and <italic toggle="yes">MLH1</italic> impairing their tumor-suppressive functions (<xref rid="ref-20" ref-type="bibr">Heydari et al., 2024</xref>). Additionally, activation of transposable elements can interfere with TSG expression or disrupt regulatory networks essential for cell cycle control and apoptosis (<xref rid="ref-14" ref-type="bibr">Gao et al., 2012</xref>; <xref rid="ref-23" ref-type="bibr">Hou et al., 2010</xref>). Our finding that GA had lower overall methylation than NS is consistent with the findings of other GC studies (<xref rid="ref-66" ref-type="bibr">Xiang et al., 2010</xref>; <xref rid="ref-34" ref-type="bibr">Leodolter et al., 2015</xref>; <xref rid="ref-49" ref-type="bibr">Park et al., 2009</xref>). These findings in GC are consistent with those in various other cancer types (<xref rid="ref-47" ref-type="bibr">Pappalardo &#x00026; Barra, 2021</xref>; <xref rid="ref-13" ref-type="bibr">Ehrlich, 2009</xref>; <xref rid="ref-37" ref-type="bibr">Luo, Lu &#x00026; Xie, 2014</xref>), supporting the consensus that genomic hypomethylation is a key event in cancer, irrespective of the tissue type. Although various factors have been suggested to be involved, the mechanism of the genome-wide process remains poorly understood. Studies in mouse models have shown that mutations in <italic toggle="yes">DNMT1</italic> cause genome-wide DNA hypomethylation, which leads to tumor formation in mice (<xref rid="ref-15" ref-type="bibr">Gaudet et al., 2003</xref>). Similarly, genome-wide methylation could be caused by the dysfunction of enzymes in the one-carbon metabolic pathway (<xref rid="ref-54" ref-type="bibr">Pogribny &#x00026; Beland, 2009</xref>). Genome-wide hypomethylation could lead to the loss of imprinting and, subsequently, the potential dysregulation of oncogenes and TSGs in those loci (<xref rid="ref-22" ref-type="bibr">Holm et al., 2005</xref>). Hypomethylation of retrotransposons such as Alu and LINE-1 may also cause their activation and transposition, leading to genomic instability (<xref rid="ref-54" ref-type="bibr">Pogribny &#x00026; Beland, 2009</xref>).</p><p>Beyond the established causal relationship between genomic hypomethylation and cancer, we aimed to determine whether genomic hypomethylation occurs progressively or abruptly in the gastric carcinogenesis cascade. A few studies have examined this change from a chronological perspective (<xref rid="ref-1" ref-type="bibr">Bae et al., 2012</xref>). Our findings align with those of <xref rid="ref-1" ref-type="bibr">Bae et al. (2012)</xref>, who also demonstrated a marked reduction in Alu methylation levels during the transition from CG to IM. Additionally, <xref rid="ref-1" ref-type="bibr">Bae et al. (2012)</xref> reported that LINE-1 methylation levels significantly differed between IM and GA, suggesting that LINE-1 and Alu hypomethylation occurs at different stages of carcinogenesis (<xref rid="ref-1" ref-type="bibr">Bae et al., 2012</xref>). However, <xref rid="ref-49" ref-type="bibr">Park et al. (2009)</xref> reported that the Alu methylation levels were similar in CG, IM, and GA but significantly decreased in the GC stage. The same authors reported that the methylation levels of other repetitive elements, LINE-1 and SAT2, decreased progressively from CG to IM to GA (<xref rid="ref-49" ref-type="bibr">Park et al., 2009</xref>). In conclusion, we propose that genome-wide DNA hypomethylation is associated with the early stages of carcinogenesis, with the results of our study suggesting that the transition from CG to IM is associated with the most significant methylation change. As hypomethylation occurs early in the gastric carcinogenesis cascade, it is a promising biomarker for the detection of precancerous lesions. Correspondingly, we conducted ROC curve analysis based on our sample data, which showed that the sensitivity and specificity reached 86.21% and 86.96%, respectively. Nevertheless, the discrepancy in the findings of different studies highlights the need for further research on the association between gastric carcinogenesis stage and hypomethylation in each repetitive element including Alu, LINE-1, SAT&#x003b1;, and/or SAT2. Our findings, in line with previous studies, highlight that Alu hypomethylation is not only a marker of genomic instability but also a potential contributor to the early stages of tumorigenesis. Given its detectability in both tissue and blood-based assays, Alu hypomethylation may serve as a valuable biomarker for early detection and risk assessment of gastric cancer. Further mechanistic studies are warranted to delineate the exact pathways by which hypomethylation promotes tumor development and to evaluate its potential utility in clinical settings (<xref rid="ref-66" ref-type="bibr">Xiang et al., 2010</xref>).</p><p>Notably, our results showed that infection with <italic toggle="yes">H. pylori</italic> is not correlated with Alu hypomethylation. Our results corroborate those of <xref rid="ref-1" ref-type="bibr">Bae et al. (2012)</xref>, <xref rid="ref-71" ref-type="bibr">Yoshida et al. (2011)</xref>. Additionally, <xref rid="ref-49" ref-type="bibr">Park et al. (2009)</xref> found that while gene-specific methylation significantly differed in CG between <italic toggle="yes">H. pylori-</italic>positive and negative samples, genome-wide methylation did not. However, <xref rid="ref-34" ref-type="bibr">Leodolter et al. (2015)</xref>, <xref rid="ref-38" ref-type="bibr">Maekita et al. (2006)</xref>, <xref rid="ref-58" ref-type="bibr">Shin et al. (2011)</xref> reported that methylation levels differed significantly between <italic toggle="yes">H. pylori</italic>-positive and -negative samples. However, the discrepancy in the results may be due to the different techniques used to estimate global gene methylation. Nevertheless, conflicting findings regarding <italic toggle="yes">H. pylori</italic> infection highlight the complexity of cancer pathogenesis and the interplay among various factors, such as infection. Similarly, EBV infection was not associated with Alu hypomethylation in our study. EBV infection has been associated with significant promoter hypermethylation in other studies (<xref rid="ref-61" ref-type="bibr">Thrift &#x00026; El-Serag, 2020</xref>; <xref rid="ref-43" ref-type="bibr">Naseem et al., 2018</xref>; <xref rid="ref-45" ref-type="bibr">Padmanabhan, Ushijima &#x00026; Tan, 2017</xref>; <xref rid="ref-46" ref-type="bibr">Palrasu et al., 2021</xref>; <xref rid="ref-40" ref-type="bibr">Matsusaka et al., 2014</xref>); however, the correlation between EBV infection and global methylation remains unclear. Although previous studies have implicated <italic toggle="yes">Helicobacter pylori</italic> (<italic toggle="yes">H. pylori</italic>) and Epstein&#x02013;Barr virus (EBV) infections in modulating DNA methylation patterns, our analysis revealed no significant differences in Alu methylation levels between infection-positive and -negative gastric tissues. Chronic <italic toggle="yes">H. pylori</italic> infection has been shown to induce inflammation-driven epigenetic reprogramming, leading to both global hypomethylation and gene-specific promoter hypermethylation (<xref rid="ref-63" ref-type="bibr">Wang et al., 2024</xref>). For instance, <xref rid="ref-34" ref-type="bibr">Leodolter et al. (2015)</xref> reported increased Alu hypomethylation in <italic toggle="yes">H. pylori</italic>-positive gastric mucosae, a finding not replicated in our study, possibly due to differences in bacterial strain virulence, host genetics, or timing of infection assessment. Conversely, <xref rid="ref-49" ref-type="bibr">Park et al. (2009)</xref> found no significant differences in global methylation, aligning with our observations and suggesting that <italic toggle="yes">H. pylori&#x02019;</italic>s effects may be confined to specific loci rather than repetitive elements. Similarly, EBV-associated gastric cancer (EBVaGC) displays a unique CpG island hypermethylation phenotype, driven by latent viral proteins such as LMP2A that upregulate DNMT1 and DNMT3B expression, leading to the silencing of tumor suppressor genes including <italic toggle="yes">CDKN2A</italic>, <italic toggle="yes">PTEN</italic>, and <italic toggle="yes">MLH1</italic> (<xref rid="ref-43" ref-type="bibr">Naseem et al., 2018</xref>) Despite these well-characterized promoter-level changes, our study detected no significant difference in Alu methylation, suggesting that EBV&#x02019;s epigenetic effects may be selective and not extend to repetitive elements (<xref rid="ref-40" ref-type="bibr">Matsusaka et al., 2014</xref>). Variations in findings across studies may stem from differences in methodology, sample size, disease stage, host epigenetic machinery, and viral strain heterogeneity (<xref rid="ref-74" ref-type="bibr">Zeng et al., 2022</xref>). Notably, some reports have proposed that co-infection with <italic toggle="yes">H. pylori</italic> and EBV may synergistically exacerbate mucosal inflammation and facilitate viral entry and persistence, further contributing to epigenetic field cancerization (<xref rid="ref-45" ref-type="bibr">Padmanabhan, Ushijima &#x00026; Tan, 2017</xref>; <xref rid="ref-46" ref-type="bibr">Palrasu et al., 2021</xref>). Therefore, while our data do not support a role for global Alu hypomethylation in relation to infection status, accumulating evidence indicates that <italic toggle="yes">H. pylori</italic> and EBV exert complex, context-dependent effects on gastric DNA methylation that merit further study using diverse methylation targets and larger, multi-institutional cohorts. The results of our study improve our understanding of the pathophysiological mechanisms underlying gastric carcinogenesis induced by <italic toggle="yes">H. pylori</italic> and EBV infections.</p><p>This study has some limitations. First, we used Alu as the only marker of global hypomethylation. However, as discussed earlier, LINE-1 and Alu hypomethylation does not occur in the same stage of carcinogenesis (<xref rid="ref-1" ref-type="bibr">Bae et al., 2012</xref>; <xref rid="ref-49" ref-type="bibr">Park et al., 2009</xref>). This may be because the mechanisms regulating the methylation of repetitive DNA sequences differ (<xref rid="ref-68" ref-type="bibr">Yang et al., 2004</xref>). Therefore, Alu methylation may not be a perfect representative of overall genome-wide methylation. The lack of subclassification of Alu elements such as Alu J, Alu S, and Alu Y, which can display distinct methylation patterns, could also limit data interpretation. Second, we did not conduct laser capture microdissection; therefore, the samples may have contained normal cells. This implies that Alu methylation results may depend on the proportion of cancer cells in the sample. Third, the sample size in our study was relatively small, especially in certain subgroups, which may limit the statistical power and generalizability of our findings. To address this limitation and validate our results, future studies should include larger cohorts from multiple institutions or integrate publicly available datas. Multi-center studies with well-characterized samples will be essential to confirm the diagnostic value of Alu hypomethylation and its utility as a biomarker in diverse populations. This study was based on formalin-fixed, paraffin-embedded (FFPE) tissue samples, which limited the ability to evaluate dynamic temporal changes in Alu methylation across successive stages of gastric carcinogenesis within the same individuals. Consequently, the progression and potential reversibility of epigenetic alterations could not be fully assessed. To address this limitation, future studies should incorporate high-resolution methylation profiling techniques&#x02014;such as bisulfite sequencing PCR (BSP), quantitative methylation-specific PCR (qMSP), or MassARRAY&#x02014;to enable more precise and comprehensive analysis. We propose that future investigations incorporate DNMT1 immunohistochemistry or other molecular approaches to better elucidate the role of DNA methyltransferase activity in the regulation of repetitive element methylation during gastric tumorigenesis. Additionally, integrating gene-specific methylation and expression data will be essential to clarify the interplay between Alu hypomethylation and the regulation of tumor suppressor genes in gastric cancer. Moreover, this study did not examine the potential involvement of DNA demethylases (<italic toggle="yes">e.g</italic>., the TET family) in regulating Alu methylation, which limits our understanding of the reversibility of epigenetic alterations in gastric cancer. Another important limitation is the lack of external validation of our ROC analysis and the absence of direct comparison with established clinical biomarkers such as CEA and CA19-9. Future studies should validate Alu methylation findings using independent cohorts&#x02014;through public databases or collaborative sample collections&#x02014;and assess its diagnostic sensitivity and specificity relative to conventional biomarkers to better define its clinical utility.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, our study showed that Alu methylation levels were lower in GC tissues than in normal tissues. In particular, the change in methylation levels was most significant from CG to IM. However, Alu methylation levels were comparable among IM, GD, and GA. Moreover, Alu methylation levels were not associated with <italic toggle="yes">H. pylori</italic> or EBV infection. Our sensitivity and specificity analyses also suggest that Alu methylation levels can be used to distinguish GC tissues from normal tissue; thus, it is a promising potential biomarker for GC diagnosis. Future studies should delve into additional repeated sequences and alternative methods of methylation detection for comparative analyses.</p></sec><sec id="supplemental-information" sec-type="supplementary-material"><title>Supplemental Information</title><supplementary-material id="supp-1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.7717/peerj.19485/supp-1</object-id><label>Supplemental Information 1</label><caption><title>Raw data: gastric methylation level.</title></caption><media xlink:href="peerj-13-19485-s001.xlsx"/></supplementary-material><supplementary-material id="supp-2" position="float" content-type="local-data"><object-id pub-id-type="doi">10.7717/peerj.19485/supp-2</object-id><label>Supplemental Information 2</label><caption><title>Supplemental Tables.</title></caption><media xlink:href="peerj-13-19485-s002.docx"/></supplementary-material></sec></body><back><ack><p>JM and SK would like to express our deepest gratitude to our beloved children, Suparoch Meevassana (AJ) and MUGI, whose presence brings profound strength and meaning to our lives. Their unconditional love and innocence have sustained us through the most challenging moments. We are especially thankful for their quiet support during countless late nights of research and writing, and for being a constant source of inspiration. Their very existence is a beautiful reminder of what truly matters and motivates us to strive for excellence in all we do.</p></ack><sec sec-type="additional-information"><title>Additional Information and Declarations</title><sec sec-type="COI-statement"><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><sec sec-type="author-contributions"><title>Author Contributions</title><p><xref rid="author-1" ref-type="contrib">Jiraroch Meevassana</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p><p><xref rid="author-2" ref-type="contrib">Chawisa Wanda Vongsuly</xref> analyzed the data, prepared figures and/or tables, and approved the final draft.</p><p><xref rid="author-3" ref-type="contrib">Tanchanok Nakbua</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.</p><p><xref rid="author-4" ref-type="contrib">Supitcha Kamolratanakul</xref> conceived and designed the experiments, performed the experiments, prepared figures and/or tables, and approved the final draft.</p><p><xref rid="author-5" ref-type="contrib">Pichaya Thitiwanichpiwong</xref> performed the experiments, authored or reviewed drafts of the article, and approved the final draft.</p><p><xref rid="author-6" ref-type="contrib">Fardeela Bin-Alee</xref> conceived and designed the experiments, performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p><p><xref rid="author-7" ref-type="contrib">Somboon Keelawat</xref> conceived and designed the experiments, performed the experiments, authored or reviewed drafts of the article, and approved the final draft.</p><p><xref rid="author-8" ref-type="contrib">Nakarin Kitkumthorn</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.</p></sec><sec sec-type="other"><title>Human Ethics</title><p>The following information was supplied relating to ethical approvals (<italic toggle="yes">i.e</italic>., approving body and any reference numbers):</p><p>Review Committee of the Medical Faculty of Chulalongkorn University in Bangkok, Thailand.</p></sec><sec sec-type="data-availability"><title>Data Availability</title><p>The following information was supplied regarding data availability:</p><p>The raw measurements are available in the <xref rid="supplemental-information" ref-type="sec">Supplemental File</xref>.</p></sec></sec><ref-list content-type="authoryear"><title>References</title><ref id="ref-1"><label>Bae et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bae</surname><given-names>JM</given-names></name>
<name><surname>Shin</surname><given-names>SH</given-names></name>
<name><surname>Kwon</surname><given-names>HJ</given-names></name>
<name><surname>Park</surname><given-names>SY</given-names></name>
<name><surname>Kook</surname><given-names>MC</given-names></name>
<name><surname>Kim</surname><given-names>YW</given-names></name>
<name><surname>Cho</surname><given-names>NY</given-names></name>
<name><surname>Kim</surname><given-names>N</given-names></name>
<name><surname>Kim</surname><given-names>TY</given-names></name>
<name><surname>Kim</surname><given-names>D</given-names></name>
<name><surname>Kang</surname><given-names>GH</given-names></name>
</person-group><article-title>ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications</article-title><source>International Journal of Cancer</source><year iso-8601-date="2012">2012</year><volume>131</volume><issue>6</issue><fpage>1323</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1002/ijc.27369</pub-id><pub-id pub-id-type="pmid">22120154</pub-id>
</element-citation></ref><ref id="ref-2"><label>Bao et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bao</surname><given-names>F</given-names></name>
<name><surname>LoVerso</surname><given-names>PR</given-names></name>
<name><surname>Fisk</surname><given-names>JN</given-names></name>
<name><surname>Zhurkin</surname><given-names>VB</given-names></name>
<name><surname>Cui</surname><given-names>F</given-names></name>
</person-group><article-title>p53 binding sites in normal and cancer cells are characterized by distinct chromatin context</article-title><source>bioRxiv</source><year iso-8601-date="2017">2017</year><pub-id pub-id-type="doi">10.1080/15384101.2017.1361064</pub-id></element-citation></ref><ref id="ref-3"><label>Baylin et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baylin</surname><given-names>SB</given-names></name>
<name><surname>Esteller</surname><given-names>M</given-names></name>
<name><surname>Rountree</surname><given-names>MR</given-names></name>
<name><surname>Bachman</surname><given-names>KE</given-names></name>
<name><surname>Schuebel</surname><given-names>K</given-names></name>
<name><surname>Herman</surname><given-names>JG</given-names></name>
</person-group><article-title>Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer</article-title><source>Human Molecular Genetics</source><year iso-8601-date="2001">2001</year><volume>10</volume><issue>7</issue><fpage>687</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1093/hmg/10.7.687</pub-id><pub-id pub-id-type="pmid">11257100</pub-id>
</element-citation></ref><ref id="ref-4"><label>Baylin &#x00026; Jones (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baylin</surname><given-names>SB</given-names></name>
<name><surname>Jones</surname><given-names>PA</given-names></name>
</person-group><article-title>Epigenetic determinants of cancer</article-title><source>Cold Spring Harbor Perspectives in Biology</source><year iso-8601-date="2016">2016</year><volume>8</volume><issue>9</issue><fpage>a019505</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a019505</pub-id><pub-id pub-id-type="pmid">27194046</pub-id>
</element-citation></ref><ref id="ref-5"><label>Belancio, Deininger &#x00026; Roy-Engel (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Belancio</surname><given-names>VP</given-names></name>
<name><surname>Deininger</surname><given-names>PL</given-names></name>
<name><surname>Roy-Engel</surname><given-names>AM</given-names></name>
</person-group><article-title>LINE dancing in the human genome: transposable elements and disease</article-title><source>Genome Medicine</source><year iso-8601-date="2009">2009</year><volume>1</volume><issue>10</issue><fpage>97</fpage><pub-id pub-id-type="doi">10.1186/gm97</pub-id><pub-id pub-id-type="pmid">19863772</pub-id>
</element-citation></ref><ref id="ref-6"><label>Besselink et al. (2023)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Besselink</surname><given-names>N</given-names></name>
<name><surname>Keijer</surname><given-names>J</given-names></name>
<name><surname>Vermeulen</surname><given-names>C</given-names></name>
<name><surname>Boymans</surname><given-names>S</given-names></name>
<name><surname>de Ridder</surname><given-names>J</given-names></name>
<name><surname>van Hoeck</surname><given-names>A</given-names></name>
<name><surname>Cuppen</surname><given-names>E</given-names></name>
<name><surname>Kuijk</surname><given-names>E</given-names></name>
</person-group><article-title>The genome-wide mutational consequences of DNA hypomethylation</article-title><source>Scientific Reports</source><year iso-8601-date="2023">2023</year><volume>13</volume><fpage>6874</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-33932-3</pub-id><pub-id pub-id-type="pmid">37106015</pub-id>
</element-citation></ref><ref id="ref-7"><label>Bhat et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bhat</surname><given-names>A</given-names></name>
<name><surname>Ghatage</surname><given-names>T</given-names></name>
<name><surname>Bhan</surname><given-names>S</given-names></name>
<name><surname>Lahane</surname><given-names>GP</given-names></name>
<name><surname>Dhar</surname><given-names>A</given-names></name>
<name><surname>Kumar</surname><given-names>R</given-names></name>
<name><surname>Pandita</surname><given-names>RK</given-names></name>
<name><surname>Bhat</surname><given-names>KM</given-names></name>
<name><surname>Ramos</surname><given-names>KS</given-names></name>
<name><surname>Pandita</surname><given-names>TK</given-names></name>
</person-group><article-title>Role of transposable elements in genome stability: implications for health and disease</article-title><source>International Journal of Molecular Sciences</source><year iso-8601-date="2022">2022</year><volume>23</volume><issue>14</issue><fpage>7802</fpage><pub-id pub-id-type="doi">10.3390/ijms23147802</pub-id><pub-id pub-id-type="pmid">35887150</pub-id>
</element-citation></ref><ref id="ref-8"><label>Bollati et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bollati</surname><given-names>V</given-names></name>
<name><surname>Galimberti</surname><given-names>D</given-names></name>
<name><surname>Pergoli</surname><given-names>L</given-names></name>
<name><surname>Dalla Valle</surname><given-names>E</given-names></name>
<name><surname>Barretta</surname><given-names>F</given-names></name>
<name><surname>Cortini</surname><given-names>F</given-names></name>
<name><surname>Scarpini</surname><given-names>E</given-names></name>
<name><surname>Bertazzi</surname><given-names>PA</given-names></name>
<name><surname>Baccarelli</surname><given-names>A</given-names></name>
</person-group><article-title>DNA methylation in repetitive elements and Alzheimer disease</article-title><source>Brain, Behavior, and Immunity</source><year iso-8601-date="2011">2011</year><volume>25</volume><issue>6</issue><fpage>1078</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2011.01.017</pub-id><pub-id pub-id-type="pmid">21296655</pub-id>
</element-citation></ref><ref id="ref-9"><label>Chaiwongkot et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chaiwongkot</surname><given-names>A</given-names></name>
<name><surname>Buranapraditkun</surname><given-names>S</given-names></name>
<name><surname>Chujan</surname><given-names>S</given-names></name>
<name><surname>Kitkumthorn</surname><given-names>N</given-names></name>
</person-group><article-title>LINE-1 and Alu methylation in hrHPV-associated precancerous cervical samples</article-title><source>Asian Pacific Journal of Cancer Prevention</source><year iso-8601-date="2022">2022</year><volume>23</volume><issue>10</issue><fpage>3443</fpage><lpage>3448</lpage><pub-id pub-id-type="doi">10.31557/APJCP.2022.23.10.3443</pub-id><pub-id pub-id-type="pmid">36308370</pub-id>
</element-citation></ref><ref id="ref-10"><label>Chenais (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chenais</surname><given-names>B</given-names></name>
</person-group><article-title>Transposable elements in cancer and other human diseases</article-title><source>Current Cancer Drug Targets</source><year iso-8601-date="2015">2015</year><volume>15</volume><issue>3</issue><fpage>227</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.2174/1568009615666150317122506</pub-id><pub-id pub-id-type="pmid">25808076</pub-id>
</element-citation></ref><ref id="ref-11"><label>Chevalier et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chevalier</surname><given-names>R</given-names></name>
<name><surname>Murcia Pienkowski</surname><given-names>V</given-names></name>
<name><surname>Jullien</surname><given-names>N</given-names></name>
<name><surname>Caron</surname><given-names>L</given-names></name>
<name><surname>Pinard</surname><given-names>PV</given-names></name>
<name><surname>Magdinier</surname><given-names>F</given-names></name>
<name><surname>Robin</surname><given-names>JD</given-names></name>
</person-group><article-title>Telomere position effect-over long distances acts as a genome-wide epigenetic regulator through a common Alu element</article-title><source>Aging Cell</source><year iso-8601-date="2025">2025</year><volume>40</volume><elocation-id>e70027</elocation-id><pub-id pub-id-type="doi">10.1111/acel.70027</pub-id></element-citation></ref><ref id="ref-12"><label>Correa &#x00026; Piazuelo (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Correa</surname><given-names>P</given-names></name>
<name><surname>Piazuelo</surname><given-names>MB</given-names></name>
</person-group><article-title>The gastric precancerous cascade</article-title><source>Journal of Digestive Diseases</source><year iso-8601-date="2012">2012</year><volume>13</volume><issue>1</issue><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1751-2980.2011.00550.x</pub-id><pub-id pub-id-type="pmid">22188910</pub-id>
</element-citation></ref><ref id="ref-13"><label>Ehrlich (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ehrlich</surname><given-names>M</given-names></name>
</person-group><article-title>DNA hypomethylation in cancer cells</article-title><source>Epigenomics</source><year iso-8601-date="2009">2009</year><volume>1</volume><issue>2</issue><fpage>239</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.2217/epi.09.33</pub-id><pub-id pub-id-type="pmid">20495664</pub-id>
</element-citation></ref><ref id="ref-14"><label>Gao et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Baccarelli</surname><given-names>A</given-names></name>
<name><surname>Shu</surname><given-names>XO</given-names></name>
<name><surname>Ji</surname><given-names>BT</given-names></name>
<name><surname>Yu</surname><given-names>K</given-names></name>
<name><surname>Tarantini</surname><given-names>L</given-names></name>
<name><surname>Yang</surname><given-names>G</given-names></name>
<name><surname>Li</surname><given-names>HL</given-names></name>
<name><surname>Hou</surname><given-names>L</given-names></name>
<name><surname>Rothman</surname><given-names>N</given-names></name>
<name><surname>Zheng</surname><given-names>W</given-names></name>
<name><surname>Gao</surname><given-names>YT</given-names></name>
<name><surname>Chow</surname><given-names>WH</given-names></name>
</person-group><article-title>Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women&#x02019;s Health Study</article-title><source>British Journal of Cancer</source><year iso-8601-date="2012">2012</year><volume>106</volume><issue>3</issue><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/bjc.2011.562</pub-id><pub-id pub-id-type="pmid">22173668</pub-id>
</element-citation></ref><ref id="ref-15"><label>Gaudet et al. (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaudet</surname><given-names>F</given-names></name>
<name><surname>Hodgson</surname><given-names>JG</given-names></name>
<name><surname>Eden</surname><given-names>A</given-names></name>
<name><surname>Jackson-Grusby</surname><given-names>L</given-names></name>
<name><surname>Dausman</surname><given-names>J</given-names></name>
<name><surname>Gray</surname><given-names>JW</given-names></name>
<name><surname>Leonhardt</surname><given-names>H</given-names></name>
<name><surname>Jaenisch</surname><given-names>R</given-names></name>
</person-group><article-title>Induction of tumors in mice by genomic hypomethylation</article-title><source>Science</source><year iso-8601-date="2003">2003</year><volume>300</volume><issue>5618</issue><fpage>489</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1126/science.1083558</pub-id><pub-id pub-id-type="pmid">12702876</pub-id>
</element-citation></ref><ref id="ref-16"><label>Gezer et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gezer</surname><given-names>U</given-names></name>
<name><surname>&#x000d6;zg&#x000fc;r</surname><given-names>E</given-names></name>
<name><surname>Y&#x000f6;r&#x000fc;ker</surname><given-names>EE</given-names></name>
<name><surname>Polatoglou</surname><given-names>E</given-names></name>
<name><surname>Holdenrieder</surname><given-names>S</given-names></name>
<name><surname>Bronkhorst</surname><given-names>A</given-names></name>
</person-group><article-title>LINE-1 cfDNA methylation as an emerging biomarker in solid cancers</article-title><source>Cancers</source><year iso-8601-date="2024">2024</year><volume>16</volume><issue>22</issue><fpage>3725</fpage><pub-id pub-id-type="doi">10.3390/cancers16223725</pub-id><pub-id pub-id-type="pmid">39594682</pub-id>
</element-citation></ref><ref id="ref-17"><label>Grewal &#x00026; Jia (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grewal</surname><given-names>SI</given-names></name>
<name><surname>Jia</surname><given-names>S</given-names></name>
</person-group><article-title>Heterochromatin revisited</article-title><source>Nature Reviews Genetics</source><year iso-8601-date="2007">2007</year><volume>8</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/nrg2008</pub-id></element-citation></ref><ref id="ref-18"><label>Gu et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>Z</given-names></name>
<name><surname>Jin</surname><given-names>K</given-names></name>
<name><surname>Crabbe</surname><given-names>MJC</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>X</given-names></name>
<name><surname>Huang</surname><given-names>Y</given-names></name>
<name><surname>Hua</surname><given-names>M</given-names></name>
<name><surname>Nan</surname><given-names>P</given-names></name>
<name><surname>Zhang</surname><given-names>Z</given-names></name>
<name><surname>Zhong</surname><given-names>Y</given-names></name>
</person-group><article-title>Enrichment analysis of Alu elements with different spatial chromatin proximity in the human genome</article-title><source>Protein &#x00026; Cell</source><year iso-8601-date="2016">2016</year><volume>7</volume><issue>4</issue><fpage>250</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1007/s13238-015-0240-7</pub-id><pub-id pub-id-type="pmid">26861146</pub-id>
</element-citation></ref><ref id="ref-19"><label>Hedrich et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hedrich</surname><given-names>CM</given-names></name>
<name><surname>M&#x000e4;bert</surname><given-names>K</given-names></name>
<name><surname>Rauen</surname><given-names>T</given-names></name>
<name><surname>Tsokos</surname><given-names>GC</given-names></name>
</person-group><article-title>DNA methylation in systemic lupus erythematosus</article-title><source>Epigenomics</source><year iso-8601-date="2017">2017</year><volume>9</volume><issue>4</issue><fpage>505</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.2217/epi-2016-0096</pub-id><pub-id pub-id-type="pmid">27885845</pub-id>
</element-citation></ref><ref id="ref-20"><label>Heydari et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heydari</surname><given-names>Z</given-names></name>
<name><surname>Moeinvaziri</surname><given-names>F</given-names></name>
<name><surname>Mirazimi</surname><given-names>SMA</given-names></name>
<name><surname>Dashti</surname><given-names>F</given-names></name>
<name><surname>Smirnova</surname><given-names>O</given-names></name>
<name><surname>Shpichka</surname><given-names>A</given-names></name>
<name><surname>Mirzaei</surname><given-names>H</given-names></name>
<name><surname>Timashev</surname><given-names>P</given-names></name>
<name><surname>Vosough</surname><given-names>M</given-names></name>
</person-group><article-title>Alteration in DNA methylation patterns: epigenetic signatures in gastrointestinal cancers</article-title><source>European Journal of Pharmacology</source><year iso-8601-date="2024">2024</year><volume>973</volume><issue>68</issue><fpage>176563</fpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2024.176563</pub-id><pub-id pub-id-type="pmid">38593929</pub-id>
</element-citation></ref><ref id="ref-21"><label>Himeda &#x00026; Jones (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Himeda</surname><given-names>CL</given-names></name>
<name><surname>Jones</surname><given-names>PL</given-names></name>
</person-group><article-title>The genetics and epigenetics of facioscapulohumeral muscular dystrophy</article-title><source>Annual Review of Genomics and Human Genetics</source><year iso-8601-date="2019">2019</year><volume>20</volume><issue>1</issue><fpage>265</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-083118-014933</pub-id></element-citation></ref><ref id="ref-22"><label>Holm et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Holm</surname><given-names>TM</given-names></name>
<name><surname>Jackson-Grusby</surname><given-names>L</given-names></name>
<name><surname>Brambrink</surname><given-names>T</given-names></name>
<name><surname>Yamada</surname><given-names>Y</given-names></name>
<name><surname>Rideout</surname><given-names>WM 3rd</given-names></name>
<name><surname>Jaenisch</surname><given-names>R</given-names></name>
</person-group><article-title>Global loss of imprinting leads to widespread tumorigenesis in adult mice</article-title><source>Cancer Cell</source><year iso-8601-date="2005">2005</year><volume>8</volume><issue>4</issue><fpage>275</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2005.09.007</pub-id><pub-id pub-id-type="pmid">16226703</pub-id>
</element-citation></ref><ref id="ref-23"><label>Hou et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>H</given-names></name>
<name><surname>Sartori</surname><given-names>S</given-names></name>
<name><surname>Gawron</surname><given-names>A</given-names></name>
<name><surname>Lissowska</surname><given-names>J</given-names></name>
<name><surname>Bollati</surname><given-names>V</given-names></name>
<name><surname>Tarantini</surname><given-names>L</given-names></name>
<name><surname>Zhang</surname><given-names>FF</given-names></name>
<name><surname>Zatonski</surname><given-names>W</given-names></name>
<name><surname>Chow</surname><given-names>WH</given-names></name>
<name><surname>Baccarelli</surname><given-names>A</given-names></name>
</person-group><article-title>Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population</article-title><source>International Journal of Cancer</source><year iso-8601-date="2010">2010</year><volume>127</volume><issue>8</issue><fpage>1866</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1002/ijc.25190</pub-id><pub-id pub-id-type="pmid">20099281</pub-id>
</element-citation></ref><ref id="ref-24"><label>Jakob et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jakob</surname><given-names>B</given-names></name>
<name><surname>Splinter</surname><given-names>J</given-names></name>
<name><surname>Conrad</surname><given-names>S</given-names></name>
<name><surname>Voss</surname><given-names>KO</given-names></name>
<name><surname>Zink</surname><given-names>D</given-names></name>
<name><surname>Durante</surname><given-names>M</given-names></name>
<name><surname>L&#x000f6;brich</surname><given-names>M</given-names></name>
<name><surname>Taucher-Scholz</surname><given-names>G</given-names></name>
</person-group><article-title>DNA double-strand breaks in heterochromatin elicit fast repair protein recruitment, histone H2AX phosphorylation and relocation to euchromatin</article-title><source>Nucleic Acids Research</source><year iso-8601-date="2011">2011</year><volume>39</volume><issue>15</issue><fpage>6489</fpage><lpage>6499</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr230</pub-id><pub-id pub-id-type="pmid">21511815</pub-id>
</element-citation></ref><ref id="ref-25"><label>Jayaraman et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jayaraman</surname><given-names>S</given-names></name>
<name><surname>Eswaran</surname><given-names>A</given-names></name>
<name><surname>Priya Veeraraghavan</surname><given-names>V</given-names></name>
<name><surname>Fazal</surname><given-names>M</given-names></name>
<name><surname>Al-Rahbi</surname><given-names>A</given-names></name>
<name><surname>Sirasanagandla</surname><given-names>SR</given-names></name>
</person-group><article-title>Implications of petrochemical exposure and epigenetic alterations on human health</article-title><source>Frontiers in Toxicology</source><year iso-8601-date="2025">2025</year><volume>7</volume><fpage>117</fpage><pub-id pub-id-type="doi">10.3389/ftox.2025.1542871</pub-id></element-citation></ref><ref id="ref-26"><label>Jeddi et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeddi</surname><given-names>F</given-names></name>
<name><surname>Faghfuri</surname><given-names>E</given-names></name>
<name><surname>Mehranfar</surname><given-names>S</given-names></name>
<name><surname>Soozangar</surname><given-names>N</given-names></name>
</person-group><article-title>The common bisulfite-conversion-based techniques to analyze DNA methylation in human cancers</article-title><source>Cancer Cell International</source><year iso-8601-date="2024">2024</year><volume>24</volume><issue>1</issue><fpage>240</fpage><pub-id pub-id-type="doi">10.1186/s12935-024-03405-2</pub-id><pub-id pub-id-type="pmid">38982390</pub-id>
</element-citation></ref><ref id="ref-27"><label>Jintaridth &#x00026; Mutirangura (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jintaridth</surname><given-names>P</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
</person-group><article-title>Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences</article-title><source>Physiological Genomics</source><year iso-8601-date="2010">2010</year><volume>41</volume><issue>2</issue><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.00146.2009</pub-id><pub-id pub-id-type="pmid">20145203</pub-id>
</element-citation></ref><ref id="ref-28"><label>Jiraboonsri et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiraboonsri</surname><given-names>S</given-names></name>
<name><surname>Hemvipat</surname><given-names>P</given-names></name>
<name><surname>Kamolratanakul</surname><given-names>S</given-names></name>
<name><surname>Bhummaphan</surname><given-names>N</given-names></name>
<name><surname>Siritientong</surname><given-names>T</given-names></name>
<name><surname>Kitkumthorn</surname><given-names>N</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
<name><surname>Meevassana</surname><given-names>J</given-names></name>
</person-group><article-title>CpG methylation changes in Alu repetitive sequences in normal aging due to diastolic hypertension in human dermal fibroblasts from the facial area</article-title><source>Biomedical Reports</source><year iso-8601-date="2024">2024</year><volume>20</volume><issue>1</issue><fpage>5</fpage><pub-id pub-id-type="doi">10.3892/br.2023.1693</pub-id><pub-id pub-id-type="pmid">38222864</pub-id>
</element-citation></ref><ref id="ref-29"><label>Jord&#x000e0; et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jord&#x000e0;</surname><given-names>M</given-names></name>
<name><surname>D&#x000ed;ez-Villanueva</surname><given-names>A</given-names></name>
<name><surname>Mallona</surname><given-names>I</given-names></name>
<name><surname>Mart&#x000ed;n</surname><given-names>B</given-names></name>
<name><surname>Lois</surname><given-names>S</given-names></name>
<name><surname>Barrera</surname><given-names>V</given-names></name>
<name><surname>Esteller</surname><given-names>M</given-names></name>
<name><surname>Vavouri</surname><given-names>T</given-names></name>
<name><surname>Peinado</surname><given-names>MA</given-names></name>
</person-group><article-title>The epigenetic landscape of Alu repeats delineates the structural and functional genomic architecture of colon cancer cells</article-title><source>Genome Research</source><year iso-8601-date="2017">2017</year><volume>27</volume><issue>1</issue><fpage>118</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1101/gr.207522.116</pub-id><pub-id pub-id-type="pmid">27999094</pub-id>
</element-citation></ref><ref id="ref-30"><label>Kanda &#x00026; Kodera (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kanda</surname><given-names>M</given-names></name>
<name><surname>Kodera</surname><given-names>Y</given-names></name>
</person-group><article-title>Recent advances in the molecular diagnostics of gastric cancer</article-title><source>World Journal of Gastroenterology</source><year iso-8601-date="2015">2015</year><volume>21</volume><issue>34</issue><fpage>9838</fpage><lpage>9852</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i34.9838</pub-id><pub-id pub-id-type="pmid">26379391</pub-id>
</element-citation></ref><ref id="ref-31"><label>Khitrinskaya, Stepanov &#x00026; Puzyrev (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khitrinskaya</surname><given-names>IY</given-names></name>
<name><surname>Stepanov</surname><given-names>VA</given-names></name>
<name><surname>Puzyrev</surname><given-names>VP</given-names></name>
</person-group><article-title>Alu repeats in the human genome</article-title><source>Molecular Biology</source><year iso-8601-date="2003">2003</year><volume>37</volume><issue>3</issue><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1023/A:1024218806634</pub-id></element-citation></ref><ref id="ref-32"><label>Kim (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JH</given-names></name>
</person-group><article-title>Chromatin remodeling and epigenetic regulation in plant DNA damage repair</article-title><source>International Journal of Molecular Sciences</source><year iso-8601-date="2019">2019</year><volume>20</volume><issue>17</issue><fpage>4093</fpage><pub-id pub-id-type="doi">10.3390/ijms20174093</pub-id><pub-id pub-id-type="pmid">31443358</pub-id>
</element-citation></ref><ref id="ref-33"><label>Lee &#x00026; Dutta (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>YS</given-names></name>
<name><surname>Dutta</surname><given-names>A</given-names></name>
</person-group><article-title>MicroRNAs in cancer</article-title><source>Annual Review of Pathology</source><year iso-8601-date="2009">2009</year><volume>4</volume><issue>1</issue><fpage>199</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1146/annurev.pathol.4.110807.092222</pub-id></element-citation></ref><ref id="ref-34"><label>Leodolter et al. (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leodolter</surname><given-names>A</given-names></name>
<name><surname>Alonso</surname><given-names>S</given-names></name>
<name><surname>Gonz&#x000e1;lez</surname><given-names>B</given-names></name>
<name><surname>Ebert</surname><given-names>MP</given-names></name>
<name><surname>Vieth</surname><given-names>M</given-names></name>
<name><surname>R&#x000f6;cken</surname><given-names>C</given-names></name>
<name><surname>Wex</surname><given-names>T</given-names></name>
<name><surname>Peitz</surname><given-names>U</given-names></name>
<name><surname>Malfertheiner</surname><given-names>P</given-names></name>
<name><surname>Perucho</surname><given-names>M</given-names></name>
</person-group><article-title>Somatic DNA hypomethylation in <italic toggle="yes">H. pylori</italic>-associated high-risk gastritis and gastric cancer: enhanced somatic hypomethylation associates with advanced stage cancer</article-title><source>Clinical and Translational Gastroenterology</source><year iso-8601-date="2015">2015</year><volume>6</volume><issue>4</issue><elocation-id>e85</elocation-id><pub-id pub-id-type="doi">10.1038/ctg.2015.14</pub-id><pub-id pub-id-type="pmid">25928808</pub-id>
</element-citation></ref><ref id="ref-35"><label>Li et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Zhou</surname><given-names>Y</given-names></name>
</person-group><article-title>Aberrant DNA methylation in esophageal squamous cell carcinoma and its clinical implications in systemic chemotherapy</article-title><source>International Journal of Medical Sciences</source><year iso-8601-date="2025">2025</year><volume>22</volume><issue>4</issue><fpage>1002</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.7150/ijms.109161</pub-id><pub-id pub-id-type="pmid">39991775</pub-id>
</element-citation></ref><ref id="ref-36"><label>Li et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Huang</surname><given-names>G</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Xie</surname><given-names>Z</given-names></name>
<name><surname>Zhou</surname><given-names>Z</given-names></name>
</person-group><article-title>Insights into the role of DNA methylation in immune cell development and autoimmune disease</article-title><source>Frontiers in Cell and Developmental Biology</source><year iso-8601-date="2021">2021</year><volume>9</volume><fpage>757318</fpage><pub-id pub-id-type="doi">10.3389/fcell.2021.757318</pub-id><pub-id pub-id-type="pmid">34790667</pub-id>
</element-citation></ref><ref id="ref-37"><label>Luo, Lu &#x00026; Xie (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>Y</given-names></name>
<name><surname>Lu</surname><given-names>X</given-names></name>
<name><surname>Xie</surname><given-names>H</given-names></name>
</person-group><article-title>Dynamic Alu methylation during normal development, aging, and tumorigenesis</article-title><source>BioMed Research International</source><year iso-8601-date="2014">2014</year><volume>2014</volume><fpage>784706</fpage><pub-id pub-id-type="doi">10.1155/2014/784706</pub-id><pub-id pub-id-type="pmid">25243180</pub-id>
</element-citation></ref><ref id="ref-38"><label>Maekita et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maekita</surname><given-names>T</given-names></name>
<name><surname>Nakazawa</surname><given-names>K</given-names></name>
<name><surname>Mihara</surname><given-names>M</given-names></name>
<name><surname>Nakajima</surname><given-names>T</given-names></name>
<name><surname>Yanaoka</surname><given-names>K</given-names></name>
<name><surname>Iguchi</surname><given-names>M</given-names></name>
<name><surname>Arii</surname><given-names>K</given-names></name>
<name><surname>Kaneda</surname><given-names>A</given-names></name>
<name><surname>Tsukamoto</surname><given-names>T</given-names></name>
<name><surname>Tatematsu</surname><given-names>M</given-names></name>
<name><surname>Tamura</surname><given-names>G</given-names></name>
<name><surname>Saito</surname><given-names>D</given-names></name>
<name><surname>Sugimura</surname><given-names>T</given-names></name>
<name><surname>Ichinose</surname><given-names>M</given-names></name>
<name><surname>Ushijima</surname><given-names>T</given-names></name>
</person-group><article-title>High levels of aberrant DNA methylation in <italic toggle="yes">Helicobacter pylori</italic>-infected gastric mucosae and its possible association with gastric cancer risk</article-title><source>Clinical Cancer Research</source><year iso-8601-date="2006">2006</year><volume>12</volume><issue>3 Pt 1</issue><fpage>989</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-2096</pub-id><pub-id pub-id-type="pmid">16467114</pub-id>
</element-citation></ref><ref id="ref-39"><label>Mangoni et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mangoni</surname><given-names>D</given-names></name>
<name><surname>Mazzetti</surname><given-names>A</given-names></name>
<name><surname>Ansaloni</surname><given-names>F</given-names></name>
<name><surname>Simi</surname><given-names>A</given-names></name>
<name><surname>Tartaglia</surname><given-names>GG</given-names></name>
<name><surname>Pandolfini</surname><given-names>L</given-names></name>
<name><surname>Gustincich</surname><given-names>S</given-names></name>
<name><surname>Sanges</surname><given-names>R</given-names></name>
</person-group><article-title>From the genome&#x02019;s perspective: bearing somatic retrotransposition to leverage the regulatory potential of L1 RNAs</article-title><source>Bioessays</source><year iso-8601-date="2025">2025</year><volume>47</volume><issue>2</issue><elocation-id>e2400125</elocation-id><pub-id pub-id-type="doi">10.1002/bies.202400125</pub-id><pub-id pub-id-type="pmid">39520370</pub-id>
</element-citation></ref><ref id="ref-40"><label>Matsusaka et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsusaka</surname><given-names>K</given-names></name>
<name><surname>Funata</surname><given-names>S</given-names></name>
<name><surname>Fukayama</surname><given-names>M</given-names></name>
<name><surname>Kaneda</surname><given-names>A</given-names></name>
</person-group><article-title>DNA methylation in gastric cancer, related to <italic toggle="yes">Helicobacter pylori</italic> and Epstein-Barr virus</article-title><source>World Journal of Gastroenterology</source><year iso-8601-date="2014">2014</year><volume>20</volume><issue>14</issue><fpage>3916</fpage><lpage>3926</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i14.3916</pub-id><pub-id pub-id-type="pmid">24744581</pub-id>
</element-citation></ref><ref id="ref-41"><label>Meevassana et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meevassana</surname><given-names>J</given-names></name>
<name><surname>Nacharoenkul</surname><given-names>P</given-names></name>
<name><surname>Wititsuwannakul</surname><given-names>J</given-names></name>
<name><surname>Kitkumthorn</surname><given-names>N</given-names></name>
<name><surname>Hamill</surname><given-names>KJ</given-names></name>
<name><surname>Angspatt</surname><given-names>A</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
</person-group><article-title>B1 repetitive sequence methylation enhances wound healing of second&#x02010;degree burns in rats</article-title><source>Biomedical Reports</source><year iso-8601-date="2022">2022</year><volume>16</volume><issue>3</issue><fpage>20</fpage><pub-id pub-id-type="doi">10.3892/br.2022.1503</pub-id><pub-id pub-id-type="pmid">35251607</pub-id>
</element-citation></ref><ref id="ref-42"><label>Meevassana et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meevassana</surname><given-names>J</given-names></name>
<name><surname>Serirodom</surname><given-names>S</given-names></name>
<name><surname>Prabsattru</surname><given-names>P</given-names></name>
<name><surname>Boonsongserm</surname><given-names>P</given-names></name>
<name><surname>Kamolratanakul</surname><given-names>S</given-names></name>
<name><surname>Siritientong</surname><given-names>T</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
<name><surname>Angspatt</surname><given-names>A</given-names></name>
</person-group><article-title>Alu repetitive sequence CpG methylation changes in burn scars</article-title><source>Burns</source><year iso-8601-date="2022">2022</year><volume>48</volume><issue>6</issue><fpage>1417</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2021.10.002</pub-id><pub-id pub-id-type="pmid">34657766</pub-id>
</element-citation></ref><ref id="ref-43"><label>Naseem et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naseem</surname><given-names>M</given-names></name>
<name><surname>Barzi</surname><given-names>A</given-names></name>
<name><surname>Brezden-Masley</surname><given-names>C</given-names></name>
<name><surname>Puccini</surname><given-names>A</given-names></name>
<name><surname>Berger</surname><given-names>MD</given-names></name>
<name><surname>Tokunaga</surname><given-names>R</given-names></name>
<name><surname>Battaglin</surname><given-names>F</given-names></name>
<name><surname>Soni</surname><given-names>S</given-names></name>
<name><surname>McSkane</surname><given-names>M</given-names></name>
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Lenz</surname><given-names>HJ</given-names></name>
</person-group><article-title>Outlooks on Epstein-Barr virus associated gastric cancer</article-title><source>Cancer Treatment Reviews</source><year iso-8601-date="2018">2018</year><volume>66</volume><issue>7</issue><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2018.03.006</pub-id><pub-id pub-id-type="pmid">29631196</pub-id>
</element-citation></ref><ref id="ref-44"><label>Oomen et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oomen</surname><given-names>ME</given-names></name>
<name><surname>Rodriguez-Terrones</surname><given-names>D</given-names></name>
<name><surname>Kurome</surname><given-names>M</given-names></name>
<name><surname>Zakhartchenko</surname><given-names>V</given-names></name>
<name><surname>Mottes</surname><given-names>L</given-names></name>
<name><surname>Simmet</surname><given-names>K</given-names></name>
<name><surname>Noll</surname><given-names>C</given-names></name>
<name><surname>Nakatani</surname><given-names>T</given-names></name>
<name><surname>Mourra-Diaz</surname><given-names>CM</given-names></name>
<name><surname>Aksoy</surname><given-names>I</given-names></name>
<name><surname>Savatier</surname><given-names>P</given-names></name>
<name><surname>G&#x000f6;ke</surname><given-names>J</given-names></name>
<name><surname>Wolf</surname><given-names>E</given-names></name>
<name><surname>Kaessmann</surname><given-names>H</given-names></name>
<name><surname>Torres-Padilla</surname><given-names>M-E</given-names></name>
</person-group><article-title>An atlas of transcription initiation reveals regulatory principles of gene and transposable element expression in early mammalian development</article-title><source>Cell</source><year iso-8601-date="2025">2025</year><volume>188</volume><issue>4</issue><fpage>1156</fpage><lpage>74.e20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2024.12.013</pub-id><pub-id pub-id-type="pmid">39837330</pub-id>
</element-citation></ref><ref id="ref-45"><label>Padmanabhan, Ushijima &#x00026; Tan (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padmanabhan</surname><given-names>N</given-names></name>
<name><surname>Ushijima</surname><given-names>T</given-names></name>
<name><surname>Tan</surname><given-names>P</given-names></name>
</person-group><article-title>How to stomach an epigenetic insult: the gastric cancer epigenome</article-title><source>Nature Reviews Gastroenterology &#x00026; Hepatology</source><year iso-8601-date="2017">2017</year><volume>14</volume><issue>8</issue><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2017.53</pub-id><pub-id pub-id-type="pmid">28513632</pub-id>
</element-citation></ref><ref id="ref-46"><label>Palrasu et al. (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Palrasu</surname><given-names>M</given-names></name>
<name><surname>Zaika</surname><given-names>E</given-names></name>
<name><surname>El-Rifai</surname><given-names>W</given-names></name>
<name><surname>Que</surname><given-names>J</given-names></name>
<name><surname>Zaika</surname><given-names>AI</given-names></name>
</person-group><article-title>Role of bacterial and viral pathogens in gastric carcinogenesis</article-title><source>Cancers</source><year iso-8601-date="2021">2021</year><volume>13</volume><issue>8</issue><fpage>1878</fpage><pub-id pub-id-type="doi">10.3390/cancers13081878</pub-id><pub-id pub-id-type="pmid">33919876</pub-id>
</element-citation></ref><ref id="ref-47"><label>Pappalardo &#x00026; Barra (2021)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pappalardo</surname><given-names>XG</given-names></name>
<name><surname>Barra</surname><given-names>V</given-names></name>
</person-group><article-title>Losing DNA methylation at repetitive elements and breaking bad</article-title><source>Epigenetics &#x00026; Chromatin</source><year iso-8601-date="2021">2021</year><volume>14</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/s13072-021-00400-z</pub-id><pub-id pub-id-type="pmid">34082816</pub-id>
</element-citation></ref><ref id="ref-48"><label>Park et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>SY</given-names></name>
<name><surname>Seo</surname><given-names>AN</given-names></name>
<name><surname>Jung</surname><given-names>HY</given-names></name>
<name><surname>Gwak</surname><given-names>JM</given-names></name>
<name><surname>Jung</surname><given-names>N</given-names></name>
<name><surname>Cho</surname><given-names>N-Y</given-names></name>
<name><surname>Kang</surname><given-names>GH</given-names></name>
</person-group><article-title>Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer</article-title><source>PLOS ONE</source><year iso-8601-date="2014">2014</year><volume>9</volume><issue>6</issue><elocation-id>e100429</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100429</pub-id><pub-id pub-id-type="pmid">24971511</pub-id>
</element-citation></ref><ref id="ref-49"><label>Park et al. (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>SY</given-names></name>
<name><surname>Yoo</surname><given-names>EJ</given-names></name>
<name><surname>Cho</surname><given-names>NY</given-names></name>
<name><surname>Kim</surname><given-names>N</given-names></name>
<name><surname>Kang</surname><given-names>GH</given-names></name>
</person-group><article-title>Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection</article-title><source>The Journal of Pathology</source><year iso-8601-date="2009">2009</year><volume>219</volume><issue>4</issue><fpage>410</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1002/path.2596</pub-id><pub-id pub-id-type="pmid">19639607</pub-id>
</element-citation></ref><ref id="ref-50"><label>Pasechnikov et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pasechnikov</surname><given-names>V</given-names></name>
<name><surname>Chukov</surname><given-names>S</given-names></name>
<name><surname>Fedorov</surname><given-names>E</given-names></name>
<name><surname>Kikuste</surname><given-names>I</given-names></name>
<name><surname>Leja</surname><given-names>M</given-names></name>
</person-group><article-title>Gastric cancer: prevention, screening and early diagnosis</article-title><source>World Journal of Gastroenterology</source><year iso-8601-date="2014">2014</year><volume>20</volume><issue>38</issue><fpage>13842</fpage><lpage>13862</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i38.13842</pub-id><pub-id pub-id-type="pmid">25320521</pub-id>
</element-citation></ref><ref id="ref-51"><label>Patchsung et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patchsung</surname><given-names>M</given-names></name>
<name><surname>Settayanon</surname><given-names>S</given-names></name>
<name><surname>Pongpanich</surname><given-names>M</given-names></name>
<name><surname>Mutirangura</surname><given-names>D</given-names></name>
<name><surname>Jintarith</surname><given-names>P</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
</person-group><article-title>Alu siRNA to increase Alu element methylation and prevent DNA damage</article-title><source>Epigenomics</source><year iso-8601-date="2018">2018</year><volume>10</volume><issue>2</issue><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.2217/epi-2017-0096</pub-id><pub-id pub-id-type="pmid">29336607</pub-id>
</element-citation></ref><ref id="ref-52"><label>Pfeifer (2000)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pfeifer</surname><given-names>GP</given-names></name>
</person-group><article-title>p53 mutational spectra and the role of methylated CpG sequences</article-title><source>Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</source><year iso-8601-date="2000">2000</year><volume>450</volume><issue>1</issue><fpage>155</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0027-5107(00)00022-1</pub-id><pub-id pub-id-type="pmid">10838140</pub-id>
</element-citation></ref><ref id="ref-53"><label>Pobsook et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pobsook</surname><given-names>T</given-names></name>
<name><surname>Subbalekha</surname><given-names>K</given-names></name>
<name><surname>Sannikorn</surname><given-names>P</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
</person-group><article-title>Improved measurement of LINE-1 sequence methylation for cancer detection</article-title><source>Clinica Chimica Acta</source><year iso-8601-date="2011">2011</year><volume>412</volume><issue>3&#x02013;4</issue><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2010.10.030</pub-id></element-citation></ref><ref id="ref-54"><label>Pogribny &#x00026; Beland (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pogribny</surname><given-names>IP</given-names></name>
<name><surname>Beland</surname><given-names>FA</given-names></name>
</person-group><article-title>DNA hypomethylation in the origin and pathogenesis of human diseases</article-title><source>Cellular and Molecular Life Sciences</source><year iso-8601-date="2009">2009</year><volume>66</volume><issue>14</issue><fpage>2249</fpage><lpage>2261</lpage><pub-id pub-id-type="doi">10.1007/s00018-009-0015-5</pub-id><pub-id pub-id-type="pmid">19326048</pub-id>
</element-citation></ref><ref id="ref-55"><label>Prucksakorn et al. (2025)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prucksakorn</surname><given-names>T</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
<name><surname>Pavasant</surname><given-names>P</given-names></name>
<name><surname>Subbalekha</surname><given-names>K</given-names></name>
</person-group><article-title>Altered methylation levels in LINE-1 in dental pulp stem cell-derived osteoblasts</article-title><source>International Dental Journal</source><year iso-8601-date="2025">2025</year><volume>75</volume><issue>2</issue><fpage>1269</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1016/j.identj.2024.09.009</pub-id><pub-id pub-id-type="pmid">39368926</pub-id>
</element-citation></ref><ref id="ref-56"><label>Shan et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shan</surname><given-names>YS</given-names></name>
<name><surname>Hsu</surname><given-names>HP</given-names></name>
<name><surname>Lai</surname><given-names>MD</given-names></name>
<name><surname>Hung</surname><given-names>YH</given-names></name>
<name><surname>Wang</surname><given-names>CY</given-names></name>
<name><surname>Yen</surname><given-names>MC</given-names></name>
<name><surname>Chen</surname><given-names>YL</given-names></name>
</person-group><article-title>Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer</article-title><source>Oncology Letters</source><year iso-8601-date="2017">2017</year><volume>14</volume><issue>4</issue><fpage>4517</fpage><lpage>4526</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.6736</pub-id><pub-id pub-id-type="pmid">28943959</pub-id>
</element-citation></ref><ref id="ref-57"><label>Sheaffer, Elliott &#x00026; Kaestner (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sheaffer</surname><given-names>KL</given-names></name>
<name><surname>Elliott</surname><given-names>EN</given-names></name>
<name><surname>Kaestner</surname><given-names>KH</given-names></name>
</person-group><article-title>DNA hypomethylation contributes to genomic instability and intestinal cancer initiation</article-title><source>Cancer Prevention Research</source><year iso-8601-date="2016">2016</year><volume>9</volume><issue>7</issue><fpage>534</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-15-0349</pub-id><pub-id pub-id-type="pmid">26883721</pub-id>
</element-citation></ref><ref id="ref-58"><label>Shin et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shin</surname><given-names>CM</given-names></name>
<name><surname>Kim</surname><given-names>N</given-names></name>
<name><surname>Jung</surname><given-names>Y</given-names></name>
<name><surname>Park</surname><given-names>JH</given-names></name>
<name><surname>Kang</surname><given-names>GH</given-names></name>
<name><surname>Park</surname><given-names>WY</given-names></name>
<name><surname>Kim</surname><given-names>JS</given-names></name>
<name><surname>Jung</surname><given-names>HC</given-names></name>
<name><surname>Song</surname><given-names>IS</given-names></name>
</person-group><article-title>Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to <italic toggle="yes">Helicobacter pylori</italic> infection and the presence of gastric cancer</article-title><source>Helicobacter</source><year iso-8601-date="2011">2011</year><volume>16</volume><issue>3</issue><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1111/j.1523-5378.2011.00838.x</pub-id><pub-id pub-id-type="pmid">21585603</pub-id>
</element-citation></ref><ref id="ref-59"><label>Smith et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>MG</given-names></name>
<name><surname>Hold</surname><given-names>GL</given-names></name>
<name><surname>Tahara</surname><given-names>E</given-names></name>
<name><surname>El-Omar</surname><given-names>EM</given-names></name>
</person-group><article-title>Cellular and molecular aspects of gastric cancer</article-title><source>World Journal of Gastroenterology</source><year iso-8601-date="2006">2006</year><volume>12</volume><issue>19</issue><fpage>2979</fpage><lpage>2990</lpage><pub-id pub-id-type="doi">10.3748/wjg.v12.i19.2979</pub-id><pub-id pub-id-type="pmid">16718776</pub-id>
</element-citation></ref><ref id="ref-60"><label>Song et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Song</surname><given-names>Z</given-names></name>
<name><surname>Wu</surname><given-names>Y</given-names></name>
<name><surname>Yang</surname><given-names>J</given-names></name>
<name><surname>Yang</surname><given-names>D</given-names></name>
<name><surname>Fang</surname><given-names>X</given-names></name>
</person-group><article-title>Progress in the treatment of advanced gastric cancer</article-title><source>Tumor Biology</source><year iso-8601-date="2017">2017</year><volume>39</volume><issue>7</issue><fpage>1010428317714626</fpage><pub-id pub-id-type="doi">10.1177/1010428317714626</pub-id><pub-id pub-id-type="pmid">28671042</pub-id>
</element-citation></ref><ref id="ref-61"><label>Thrift &#x00026; El-Serag (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thrift</surname><given-names>AP</given-names></name>
<name><surname>El-Serag</surname><given-names>HB</given-names></name>
</person-group><article-title>Burden of gastric cancer</article-title><source>Clinical Gastroenterology and Hepatology</source><year iso-8601-date="2020">2020</year><volume>18</volume><issue>3</issue><fpage>534</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2019.07.045</pub-id><pub-id pub-id-type="pmid">31362118</pub-id>
</element-citation></ref><ref id="ref-62"><label>Tremblay &#x00026; Jiang (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tremblay</surname><given-names>MW</given-names></name>
<name><surname>Jiang</surname><given-names>YH</given-names></name>
</person-group><article-title>DNA methylation and susceptibility to autism spectrum disorder</article-title><source>Annual Review of Medicine</source><year iso-8601-date="2019">2019</year><volume>70</volume><issue>1</issue><fpage>151</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-120417-091431</pub-id></element-citation></ref><ref id="ref-63"><label>Wang et al. (2024)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Dong</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>H</given-names></name>
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Miao</surname><given-names>T</given-names></name>
<name><surname>Mohseni</surname><given-names>G</given-names></name>
<name><surname>Du</surname><given-names>L</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
</person-group><article-title>DNA methylation drives a new path in gastric cancer early detection: current impact and prospects</article-title><source>Genes &#x00026; Diseases</source><year iso-8601-date="2024">2024</year><volume>11</volume><issue>2</issue><fpage>847</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1016/j.gendis.2023.02.038</pub-id><pub-id pub-id-type="pmid">37692483</pub-id>
</element-citation></ref><ref id="ref-64"><label>Wang et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>N</given-names></name>
<name><surname>Tan</surname><given-names>HY</given-names></name>
<name><surname>Feng</surname><given-names>YG</given-names></name>
<name><surname>Zhang</surname><given-names>C</given-names></name>
<name><surname>Chen</surname><given-names>F</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
</person-group><article-title>microRNA-23a in human cancer: its roles, mechanisms and therapeutic relevance</article-title><source>Cancers</source><year iso-8601-date="2018">2018</year><volume>11</volume><issue>1</issue><fpage>7</fpage><pub-id pub-id-type="doi">10.3390/cancers11010007</pub-id><pub-id pub-id-type="pmid">30577536</pub-id>
</element-citation></ref><ref id="ref-65"><label>Xia &#x00026; Aadam (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xia</surname><given-names>JY</given-names></name>
<name><surname>Aadam</surname><given-names>AA</given-names></name>
</person-group><article-title>Advances in screening and detection of gastric cancer</article-title><source>Journal of Surgical Oncology</source><year iso-8601-date="2022">2022</year><volume>125</volume><issue>7</issue><fpage>1104</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1002/jso.26844</pub-id><pub-id pub-id-type="pmid">35481909</pub-id>
</element-citation></ref><ref id="ref-66"><label>Xiang et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiang</surname><given-names>S</given-names></name>
<name><surname>Liu</surname><given-names>Z</given-names></name>
<name><surname>Zhang</surname><given-names>B</given-names></name>
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Zhu</surname><given-names>B-D</given-names></name>
<name><surname>Ji</surname><given-names>J</given-names></name>
<name><surname>Deng</surname><given-names>D</given-names></name>
</person-group><article-title>Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas</article-title><source>BMC Cancer</source><year iso-8601-date="2010">2010</year><volume>10</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-10-44</pub-id><pub-id pub-id-type="pmid">20163738</pub-id>
</element-citation></ref><ref id="ref-67"><label>Xu, Xu &#x00026; Price (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Xu</surname><given-names>C</given-names></name>
<name><surname>Price</surname><given-names>BD</given-names></name>
</person-group><article-title>Mechanistic links between ATM and histone methylation codes during DNA repair</article-title><source>Progress in Molecular Biology and Translational Science</source><year iso-8601-date="2012">2012</year><volume>110</volume><fpage>263</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-387665-2.00010-9</pub-id><pub-id pub-id-type="pmid">22749149</pub-id>
</element-citation></ref><ref id="ref-68"><label>Yang et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>AS</given-names></name>
<name><surname>Est&#x000e9;cio</surname><given-names>MR</given-names></name>
<name><surname>Doshi</surname><given-names>K</given-names></name>
<name><surname>Kondo</surname><given-names>Y</given-names></name>
<name><surname>Tajara</surname><given-names>EH</given-names></name>
<name><surname>Issa</surname><given-names>JP</given-names></name>
</person-group><article-title>A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements</article-title><source>Nucleic Acids Research</source><year iso-8601-date="2004">2004</year><volume>32</volume><issue>3</issue><elocation-id>e38</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gnh032</pub-id><pub-id pub-id-type="pmid">14973332</pub-id>
</element-citation></ref><ref id="ref-69"><label>Ye et al. (2020)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>D</given-names></name>
<name><surname>Jiang</surname><given-names>D</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Mao</surname><given-names>Y</given-names></name>
</person-group><article-title>Alu methylation and risk of cancer: a meta-analysis</article-title><source>The American Journal of the Medical Sciences</source><year iso-8601-date="2020">2020</year><volume>359</volume><issue>5</issue><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.amjms.2020.03.002</pub-id><pub-id pub-id-type="pmid">32268941</pub-id>
</element-citation></ref><ref id="ref-70"><label>Yooyongsatit et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yooyongsatit</surname><given-names>S</given-names></name>
<name><surname>Ruchusatsawat</surname><given-names>K</given-names></name>
<name><surname>Supiyaphun</surname><given-names>P</given-names></name>
<name><surname>Noppakun</surname><given-names>N</given-names></name>
<name><surname>Mutirangura</surname><given-names>A</given-names></name>
<name><surname>Wongpiyabovorn</surname><given-names>J</given-names></name>
</person-group><article-title>Alterations in the LINE-1 methylation pattern in patients with lichen simplex chronicus</article-title><source>Asian Pacific Journal of Allergy and Immunology</source><year iso-8601-date="2013">2013</year><volume>31</volume><issue>1</issue><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">23517394</pub-id>
</element-citation></ref><ref id="ref-71"><label>Yoshida et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoshida</surname><given-names>T</given-names></name>
<name><surname>Yamashita</surname><given-names>S</given-names></name>
<name><surname>Takamura-Enya</surname><given-names>T</given-names></name>
<name><surname>Niwa</surname><given-names>T</given-names></name>
<name><surname>Ando</surname><given-names>T</given-names></name>
<name><surname>Enomoto</surname><given-names>S</given-names></name>
<name><surname>Maekita</surname><given-names>T</given-names></name>
<name><surname>Nakazawa</surname><given-names>K</given-names></name>
<name><surname>Tatematsu</surname><given-names>M</given-names></name>
<name><surname>Ichinose</surname><given-names>M</given-names></name>
<name><surname>Ushijima</surname><given-names>T</given-names></name>
</person-group><article-title>Alu and Sat&#x003b1; hypomethylation in <italic toggle="yes">Helicobacter pylori</italic>-infected gastric mucosae</article-title><source>International Journal of Cancer</source><year iso-8601-date="2011">2011</year><volume>128</volume><issue>1</issue><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1002/ijc.25534</pub-id><pub-id pub-id-type="pmid">20602342</pub-id>
</element-citation></ref><ref id="ref-72"><label>You &#x00026; Jones (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>You</surname><given-names>JS</given-names></name>
<name><surname>Jones</surname><given-names>PA</given-names></name>
</person-group><article-title>Cancer genetics and epigenetics: two sides of the same coin?</article-title><source>Cancer Cell</source><year iso-8601-date="2012">2012</year><volume>22</volume><issue>1</issue><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2012.06.008</pub-id><pub-id pub-id-type="pmid">22789535</pub-id>
</element-citation></ref><ref id="ref-73"><label>Y&#x000fc;ksel et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Y&#x000fc;ksel</surname><given-names>&#x0015e;</given-names></name>
<name><surname>Kucukazman</surname><given-names>SO</given-names></name>
<name><surname>Karata&#x0015f;</surname><given-names>GS</given-names></name>
<name><surname>Ozturk</surname><given-names>MA</given-names></name>
<name><surname>Prombhul</surname><given-names>S</given-names></name>
<name><surname>Hirankarn</surname><given-names>N</given-names></name>
</person-group><article-title>Methylation status of alu and LINE-1 interspersed repetitive sequences in Behcet&#x02019;s disease patients</article-title><source>BioMed Research International</source><year iso-8601-date="2016">2016</year><volume>2016</volume><fpage>1393089</fpage><pub-id pub-id-type="doi">10.1155/2016/1393089</pub-id><pub-id pub-id-type="pmid">27123441</pub-id>
</element-citation></ref><ref id="ref-74"><label>Zeng et al. (2022)</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>Y</given-names></name>
<name><surname>Rong</surname><given-names>H</given-names></name>
<name><surname>Xu</surname><given-names>J</given-names></name>
<name><surname>Cao</surname><given-names>R</given-names></name>
<name><surname>Li</surname><given-names>S</given-names></name>
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Cheng</surname><given-names>B</given-names></name>
<name><surname>Zhou</surname><given-names>T</given-names></name>
</person-group><article-title>DNA methylation: an important biomarker and therapeutic target for gastric cancer</article-title><source>Frontiers in Genetics</source><year iso-8601-date="2022">2022</year><volume>13</volume><fpage>2055</fpage><pub-id pub-id-type="doi">10.3389/fgene.2022.823905</pub-id></element-citation></ref></ref-list></back></article>